data_2e5e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e5e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.827 0.346 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.413 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.409 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 51' ' ' TRP . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD23 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.42 ' CZ3' HD23 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 HD13 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.439 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CZ2' ' CH2' ' A' ' 51' ' ' TRP . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.589 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.456 ' CE3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' CE3' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.413 HD22 ' CH2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.42 ' CE2' HD11 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.439 0 CA-C-O 120.577 0.227 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.695 0.284 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 51' ' ' TRP . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 24' ' ' GLN . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 CA-C-O 120.693 0.282 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.415 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.424 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 ' CD1' ' A' ' 97' ' ' PHE . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CD1' HG23 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CZ2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.419 HD22 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' O ' ' CG2' ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.413 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.405 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.265 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CZ2' ' CH2' ' A' ' 51' ' ' TRP . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.434 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' A' ' 24' ' ' GLN . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 CA-C-O 120.71 0.29 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.478 ' CG2' ' CD2' ' A' ' 85' ' ' PHE . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HG2' ' CD2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.478 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 97' ' ' PHE . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.527 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.49 0.186 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.412 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.481 ' CG2' ' CD2' ' A' ' 85' ' ' PHE . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.426 ' HB3' ' CZ3' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.536 0.208 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 61' ' ' TRP . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 76' ' ' ALA . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' O ' ' CE2' ' A' ' 97' ' ' PHE . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 121.116 0.484 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.414 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.856 0.36 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.406 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.416 ' CZ2' HD23 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.416 HD23 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CG2' ' ND2' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.403 ' ND2' ' CG2' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.406 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 85' ' ' PHE . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.05 0.452 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.428 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.424 ' CZ2' ' HB1' ' A' ' 76' ' ' ALA . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD21 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.61 176.9 12.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.96 142.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.987 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.55 116.07 20.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.345 0.073 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.21 -166.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.278 1.985 . . . . 0.0 112.221 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -23.02 57.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.42 165.36 9.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.82 167.69 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.6 2.2 . . . . 0.0 112.256 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.29 105.54 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.611 2.208 . . . . 0.0 112.181 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -176.04 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.26 21.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.758 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.413 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.409 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 51' ' ' TRP . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD23 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.42 ' CZ3' HD23 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 HD13 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.439 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.9 125.69 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.32 163.04 23.34 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.061 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.242 0.69 0 C-N-CA 122.719 2.28 . . . . 0.0 112.553 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.82 0.343 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mtm -134.62 152.24 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.84 175.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -21.87 1.76 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.26 105.31 0.51 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.563 0.22 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.96 -160.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.899 2.4 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -73.11 -19.46 61.14 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.391 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -100.67 143.71 27.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.59 108.27 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 122.281 1.988 . . . . 0.0 112.138 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 139.25 38.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.532 2.155 . . . . 0.0 112.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -128.18 5.65 5.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.487 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 146.61 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CZ2' ' CH2' ' A' ' 51' ' ' TRP . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.408 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -73.35 146.28 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.7 147.03 36.73 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.728 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.997 2.465 . . . . 0.0 112.306 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.6 mtt -73.73 172.83 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.56 129.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.99 -155.58 9.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.82 170.78 8.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.68 -158.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.711 2.274 . . . . 0.0 112.291 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.73 28.97 3.56 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -81.39 146.3 57.4 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.999 0.428 . . . . 0.0 110.786 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 57.6 Cg_exo -50.52 -46.18 30.85 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.515 2.143 . . . . 0.0 112.059 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 2.9 Cg_exo -75.91 80.69 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.774 2.316 . . . . 0.0 112.016 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.0 92.51 4.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.21 133.34 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.456 ' CE3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' CD2' ' CE3' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 HD22 ' CH2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.42 ' CE2' HD11 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -73.01 146.67 45.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.29 145.57 31.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.24 0.618 0 C-N-CA 122.941 2.427 . . . . 0.0 112.387 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.868 0.365 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.01 175.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.31 -172.33 0.03 OUTLIER 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.1 -101.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 160.48 70.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.725 0.298 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.94 178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.578 2.185 . . . . 0.0 112.293 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -61.93 -18.53 60.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -57.51 157.04 14.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.98 130.87 36.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.664 2.243 . . . . 0.0 112.247 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -54.94 143.41 72.61 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.258 . . . . 0.0 112.562 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.67 -24.62 10.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.93 146.78 9.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.717 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 51' ' ' TRP . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.409 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 24' ' ' GLN . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.85 145.88 50.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.95 104.2 55.85 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.244 0.82 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.97 159.96 41.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.07 162.71 5.45 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.28 -69.83 0.1 OUTLIER Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.85 167.45 5.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 -178.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.574 2.183 . . . . 0.0 112.338 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -21.32 63.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.41 163.19 60.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.311 . . . . 0.0 110.79 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.72 146.1 28.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.334 2.023 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.29 147.41 36.35 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 122.735 2.29 . . . . 0.0 112.491 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.97 -23.99 11.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.198 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.17 151.25 2.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.82 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.415 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -73.28 133.99 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.47 137.9 23.41 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.254 1.297 0 C-N-CA 122.256 1.97 . . . . 0.0 111.821 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.6 mtm -140.06 158.11 44.58 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -177.1 176.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.47 168.29 11.32 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.23 141.82 90.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 0.0 111.035 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.22 176.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.485 2.123 . . . . 0.0 112.126 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.66 -18.93 17.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.235 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -57.54 -45.49 99.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.275 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -65.57 141.86 68.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.128 . . . . 0.0 112.093 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.93 88.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.514 2.143 . . . . 0.0 112.41 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -151.18 -175.98 5.38 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.959 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -132.78 175.82 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.424 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 ' CD1' ' A' ' 97' ' ' PHE . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CD1' HG23 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -111.15 145.91 37.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.36 104.24 53.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.471 2.114 . . . . 0.0 112.3 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.588 0.232 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.8 mmt 60.73 -176.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.72 -173.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.198 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.87 -44.41 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.55 170.21 1.47 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.72 -162.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.729 2.286 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -58.36 -22.07 52.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -94.72 152.76 40.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.6 141.98 47.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.531 2.154 . . . . 0.0 112.199 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.64 156.55 49.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.58 2.186 . . . . 0.0 112.269 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -101.66 -20.65 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -128.07 136.18 50.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.447 ' CZ2' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.419 HD22 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' O ' ' CG2' ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.413 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.405 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -105.45 139.8 39.52 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.24 149.17 44.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.588 2.192 . . . . 0.0 112.251 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.942 0.401 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.2 mmm -81.28 -179.22 7.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.158 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.59 158.17 2.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.64 -78.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.59 119.85 77.42 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.556 0.217 . . . . 0.0 111.309 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.69 170.6 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.529 2.153 . . . . 0.0 111.86 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -59.32 -21.77 60.25 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.67 160.22 36.88 Favored Pre-proline 0 C--O 1.221 -0.424 0 CA-C-O 121.473 0.654 . . . . 0.0 110.659 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.35 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.802 2.335 . . . . 0.0 111.798 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.48 136.95 44.93 Favored 'Trans proline' 0 C--O 1.216 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 112.169 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -60.14 -27.93 67.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.7 143.47 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CZ2' ' CH2' ' A' ' 51' ' ' TRP . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.434 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' A' ' 24' ' ' GLN . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 145.9 46.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.9 145.38 32.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 122.316 2.01 . . . . 0.0 112.355 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.85 -172.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -172.45 162.37 5.3 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.076 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 ' CG2' ' CD2' ' A' ' 85' ' ' PHE . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.0 -62.0 0.11 Allowed Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 146.92 88.21 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-O 120.842 0.353 . . . . 0.0 111.123 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.77 -171.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -19.44 62.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -53.34 161.28 1.46 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.53 159.77 0.46 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.587 2.191 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.97 176.92 3.99 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.978 2.452 . . . . 0.0 112.4 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.86 -167.82 0.8 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -54.17 150.14 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.837 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HG2' ' CD2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.478 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 97' ' ' PHE . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.55 145.57 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 157.66 44.81 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.121 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.68 2.253 . . . . 0.0 111.846 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 mmt -138.44 159.41 42.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.19 143.72 55.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.74 -28.1 0.25 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.83 121.32 44.34 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.437 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.71 -164.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 122.221 1.947 . . . . 0.0 111.838 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -19.98 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.88 139.68 46.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.62 112.98 1.22 Allowed 'Trans proline' 0 N--CA 1.475 0.418 0 C-N-CA 122.312 2.008 . . . . 0.0 112.17 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.17 -166.9 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.512 2.141 . . . . 0.0 112.125 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.06 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.397 0.618 . . . . 0.0 111.343 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.66 141.14 42.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.353 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.412 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' CZ2' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -84.72 128.84 34.81 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.41 161.33 32.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.783 2.322 . . . . 0.0 111.992 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -79.15 171.26 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -176.03 163.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.481 ' CG2' ' CD2' ' A' ' 85' ' ' PHE . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.01 158.53 9.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.59 4.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.498 0.189 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.95 166.74 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -103.88 15.74 27.96 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.082 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 5.9 mtmt -85.77 -47.72 0.58 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 120.791 0.329 . . . . 0.0 111.297 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 84.8 Cg_endo -83.18 140.08 9.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.379 2.053 . . . . 0.0 112.381 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.66 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.264 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.74 147.08 42.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -88.51 145.87 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' HB3' ' CZ3' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -73.29 136.68 44.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.08 149.27 42.29 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.473 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.592 2.195 . . . . 0.0 112.28 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.97 152.3 33.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.602 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.26 40.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.409 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.29 15.31 8.4 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.5 128.13 93.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.523 0.201 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.01 -174.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.267 1.978 . . . . 0.0 112.079 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.82 -20.7 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.227 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -63.72 141.22 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 31.6 Cg_exo -56.94 -45.96 32.55 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.459 2.106 . . . . 0.0 112.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 51.1 Cg_exo -54.07 -35.94 83.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.16 1.907 . . . . 0.0 112.543 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 62.56 111.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -107.97 133.38 52.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 61' ' ' TRP . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 76' ' ' ALA . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB2' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD1' HG21 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' O ' ' CE2' ' A' ' 97' ' ' PHE . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.3 139.24 38.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.23 155.96 49.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.976 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.546 2.164 . . . . 0.0 112.325 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.777 0.323 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 81.1 mtp -69.46 160.23 31.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.07 140.26 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.73 -35.79 0.68 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.23 46.01 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.461 0.172 . . . . 0.0 111.089 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 33.4 Cg_exo -58.33 -158.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.571 2.181 . . . . 0.0 111.748 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.11 -32.38 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.293 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 11.7 mttt -80.66 -64.35 0.3 Allowed Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' CD ' ' HB2' ' A' ' 44' ' ' LYS . 23.2 Cg_endo -61.02 173.17 2.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.39 2.06 . . . . 0.0 112.101 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 -166.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.747 2.298 . . . . 0.0 112.199 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.95 83.21 2.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.19 138.42 47.66 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.561 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 76' ' ' ALA . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 72' ' ' TRP . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.414 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -84.85 139.02 32.2 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.72 134.63 22.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.168 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.318 2.012 . . . . 0.0 112.553 179.817 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.832 0.349 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.36 177.3 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.89 158.47 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.165 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.406 ' CG2' ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.43 -35.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.19 105.13 0.49 Allowed Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.03 -162.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.224 1.949 . . . . 0.0 112.213 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -68.33 -22.1 64.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -102.2 138.75 19.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.56 110.7 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.749 2.299 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.2 -167.96 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 30.61 0.3 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -165.68 147.76 7.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.416 ' CZ2' HD23 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.416 HD23 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CG2' ' ND2' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.403 ' ND2' ' CG2' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.406 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -72.61 127.45 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -109.95 104.12 54.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.254 1.319 0 C-N-CA 122.468 2.112 . . . . 0.0 112.747 179.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.767 0.318 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.65 168.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.71 -177.56 0.11 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 85' ' ' PHE . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.4 -66.98 0.24 Allowed Glycine 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.95 172.38 2.34 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.649 0.262 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.26 -166.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.61 2.207 . . . . 0.0 112.426 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -23.28 23.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.319 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -102.3 138.48 19.72 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.1 144.78 56.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.182 1.922 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 147.81 31.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.505 2.136 . . . . 0.0 112.485 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -76.71 -22.11 54.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.106 0.479 . . . . 0.0 111.262 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 141.6 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.704 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.428 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.424 ' CZ2' ' HB1' ' A' ' 76' ' ' ALA . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' ' CZ2' ' A' ' 72' ' ' TRP . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD21 ' CZ2' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HG ' ' CB ' ' A' ' 76' ' ' ALA . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.06 145.86 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -114.75 104.0 54.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.004 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.488 2.125 . . . . 0.0 112.288 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.827 0.346 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' HD12 ' A' ' 34' ' ' LEU . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.788 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LEU . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.689 ' HB2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.699 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.521 ' HA ' HD21 ' A' ' 53' ' ' LEU . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.86 HD21 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.86 ' CZ3' HD21 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 83' ' ' SER . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.799 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.69 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.788 ' CD1' HG22 ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.708 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.621 HG13 ' CB ' ' A' ' 93' ' ' ASP . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.621 ' CB ' HG13 ' A' ' 89' ' ' VAL . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.688 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' HD12 ' A' ' 34' ' ' LEU . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 33' ' ' PRO . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 60' ' ' ALA . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.803 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' C ' HD21 ' A' ' 53' ' ' LEU . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.763 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.803 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.806 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HD2' HD23 ' A' ' 79' ' ' LEU . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 83' ' ' SER . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.609 HG22 HD22 ' A' ' 86' ' ' LEU . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.486 ' N ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.622 ' OE2' HG22 ' A' ' 117' ' ' VAL . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.803 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.636 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.3 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.877 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.851 ' O ' HD22 ' A' ' 34' ' ' LEU . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 33' ' ' PRO . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.776 HG22 ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.589 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 HD13 ' A' ' 64' ' ' LEU . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.03 HD11 ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' HZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HZ3' ' HG1' ' A' ' 55' ' ' THR . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.781 HD13 HD23 ' A' ' 49' ' ' LEU . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.586 ' HH2' HD11 ' A' ' 84' ' ' LEU . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' HD23 ' A' ' 86' ' ' LEU . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 83' ' ' SER . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.76 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.586 HD11 ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 117' ' ' VAL . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' CB ' HG13 ' A' ' 89' ' ' VAL . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 49' ' ' LEU . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.877 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.64 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.0 mt-30 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.439 0 CA-C-O 120.577 0.227 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.91 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 34' ' ' LEU . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.695 0.284 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 64' ' ' LEU . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 55' ' ' THR . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 59' ' ' GLU . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' N ' HD11 ' A' ' 53' ' ' LEU . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 49' ' ' LEU . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.568 ' HH2' HD21 ' A' ' 84' ' ' LEU . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 86' ' ' LEU . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 83' ' ' SER . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 83' ' ' SER . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.694 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 ' HH2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.775 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.518 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.75 HG23 ' OE1' ' A' ' 94' ' ' GLU . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 117' ' ' VAL . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG13 ' HG2' ' A' ' 114' ' ' ARG . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.656 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HG13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.91 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.87 ' HB2' HG21 ' A' ' 89' ' ' VAL . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG22 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 CA-C-O 120.693 0.282 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 64' ' ' LEU . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.509 HD22 ' HE1' ' A' ' 97' ' ' PHE . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 49' ' ' LEU . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.669 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.669 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.759 ' CD1' HG22 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.476 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 92' ' ' GLN . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HG3' HD12 ' A' ' 91' ' ' ILE . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.598 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' CG ' HG13 ' A' ' 117' ' ' VAL . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.509 ' HE1' HD22 ' A' ' 53' ' ' LEU . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' H ' HG22 ' A' ' 109' ' ' THR . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 101' ' ' ALA . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' ASN . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.899 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.829 ' O ' HG12 ' A' ' 89' ' ' VAL . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 33' ' ' PRO . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 64' ' ' LEU . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 61' ' ' TRP . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.62 ' N ' HD21 ' A' ' 53' ' ' LEU . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 49' ' ' LEU . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.736 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 86' ' ' LEU . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.731 ' CD1' HG22 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 32' ' ' GLU . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.625 ' OE2' HG22 ' A' ' 117' ' ' VAL . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.899 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' C ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.917 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.759 ' CE3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.697 ' CH2' HD21 ' A' ' 84' ' ' LEU . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 78' ' ' VAL . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 79' ' ' LEU . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.899 ' HB2' HG22 ' A' ' 89' ' ' VAL . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 34' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.496 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.812 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 96' ' ' ILE . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 109' ' ' THR . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.882 ' HB ' HG23 ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.265 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.691 HD11 ' HD2' ' A' ' 113' ' ' TYR . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.925 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' C ' HD12 ' A' ' 34' ' ' LEU . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.592 HD21 ' N ' ' A' ' 61' ' ' TRP . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.592 ' N ' HD21 ' A' ' 53' ' ' LEU . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HH2' HD21 ' A' ' 84' ' ' LEU . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' SER . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.802 ' CD1' HG22 ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 HD23 ' A' ' 84' ' ' LEU . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 30' ' ' ILE . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 91' ' ' ILE . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.606 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.642 ' CD ' HG22 ' A' ' 117' ' ' VAL . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' ' 96' ' ' ILE . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.691 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.925 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 CA-C-O 120.71 0.29 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 113' ' ' TYR . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.821 ' O ' HD22 ' A' ' 34' ' ' LEU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 84' ' ' LEU . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 61' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.715 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.522 ' N ' HD11 ' A' ' 53' ' ' LEU . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HE3' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 64' ' ' LEU . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' HE3' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.686 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB3' HD13 ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.756 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 79' ' ' LEU . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.805 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 34' ' ' LEU . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' CB ' HG13 ' A' ' 89' ' ' VAL . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.715 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' HD11 ' A' ' 26' ' ' ILE . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.865 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.527 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.848 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.815 ' O ' HD22 ' A' ' 34' ' ' LEU . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.49 0.186 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.888 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CD2' ' A' ' 86' ' ' LEU . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 83' ' ' SER . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' OE1' ' A' ' 94' ' ' GLU . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' CB ' HG13 ' A' ' 89' ' ' VAL . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.745 ' CD ' HG22 ' A' ' 117' ' ' VAL . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 102' ' ' MET . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 93' ' ' ASP . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.848 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.6 mt-30 . . . . . 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.922 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.755 ' C ' HD22 ' A' ' 34' ' ' LEU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 33' ' ' PRO . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 84' ' ' LEU . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 64' ' ' LEU . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' C ' ' A' ' 60' ' ' ALA . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 95' ' ' GLY . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' C ' HD21 ' A' ' 53' ' ' LEU . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.54 ' N ' HD11 ' A' ' 53' ' ' LEU . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 49' ' ' LEU . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.59 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 83' ' ' SER . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 85' ' ' PHE . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.587 ' HB3' HD13 ' A' ' 79' ' ' LEU . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.728 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 79' ' ' LEU . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.72 HG22 HD22 ' A' ' 86' ' ' LEU . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.563 ' CB ' HG13 ' A' ' 89' ' ' VAL . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.637 ' CD ' HG22 ' A' ' 117' ' ' VAL . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 55' ' ' THR . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 8.5 t30 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.922 ' HB ' HG23 ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.8 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.536 0.208 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 ' CE1' ' A' ' 97' ' ' PHE . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 53' ' ' LEU . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.557 ' CH2' HD11 ' A' ' 84' ' ' LEU . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 83' ' ' SER . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.758 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CH2' ' A' ' 72' ' ' TRP . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD22 ' OD2' ' A' ' 93' ' ' ASP . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 34' ' ' LEU . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 92' ' ' GLN . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.797 ' OD2' HD22 ' A' ' 86' ' ' LEU . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 117' ' ' VAL . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.918 ' CE1' HD22 ' A' ' 53' ' ' LEU . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.845 ' HB ' HG23 ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.534 ' O ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.886 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 89' ' ' VAL . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 121.116 0.484 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 60' ' ' ALA . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 59' ' ' GLU . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.534 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.86 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 83' ' ' SER . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 83' ' ' SER . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.724 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.86 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 34' ' ' LEU . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' HD21 ' A' ' 86' ' ' LEU . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.893 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 55' ' ' THR . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 109' ' ' THR . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' HD11 ' A' ' 26' ' ' ILE . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.893 HG22 ' OE2' ' A' ' 94' ' ' GLU . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.856 0.36 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' HD2' ' A' ' 113' ' ' TYR . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.834 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.796 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 83' ' ' SER . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.834 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.821 HG23 ' OE1' ' A' ' 94' ' ' GLU . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.821 ' OE1' HG23 ' A' ' 91' ' ' ILE . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.581 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.517 ' HD2' HD11 ' A' ' 26' ' ' ILE . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.901 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.8 ' O ' HD22 ' A' ' 34' ' ' LEU . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.802 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 36' ' ' LEU . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.05 0.452 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.514 ' CZ3' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 60' ' ' ALA . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.798 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.481 ' HH2' HD21 ' A' ' 84' ' ' LEU . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 86' ' ' LEU . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 83' ' ' SER . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.588 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.75 HD22 ' OD2' ' A' ' 93' ' ' ASP . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HB2' ' A' ' 34' ' ' LEU . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.75 ' OD2' HD22 ' A' ' 86' ' ' LEU . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 117' ' ' VAL . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.702 ' HA ' HG22 ' A' ' 109' ' ' THR . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.702 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.842 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' ILE . 27.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.61 176.9 12.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.96 142.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.987 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' HD12 ' A' ' 34' ' ' LEU . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.788 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LEU . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.55 116.07 20.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.345 0.073 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.21 -166.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.278 1.985 . . . . 0.0 112.221 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -23.02 57.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.42 165.36 9.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.82 167.69 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.6 2.2 . . . . 0.0 112.256 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.29 105.54 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.611 2.208 . . . . 0.0 112.181 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -176.04 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.26 21.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.758 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.689 ' HB2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.699 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.521 ' HA ' HD21 ' A' ' 53' ' ' LEU . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.86 HD21 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.86 ' CZ3' HD21 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 83' ' ' SER . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.799 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.69 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.788 ' CD1' HG22 ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.708 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.621 HG13 ' CB ' ' A' ' 93' ' ' ASP . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.621 ' CB ' HG13 ' A' ' 89' ' ' VAL . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.688 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -79.9 125.69 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.32 163.04 23.34 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.061 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.242 0.69 0 C-N-CA 122.719 2.28 . . . . 0.0 112.553 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.82 0.343 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mtm -134.62 152.24 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.84 175.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' HD12 ' A' ' 34' ' ' LEU . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 33' ' ' PRO . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -21.87 1.76 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.26 105.31 0.51 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.563 0.22 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.96 -160.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.899 2.4 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -73.11 -19.46 61.14 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.391 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -100.67 143.71 27.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.59 108.27 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 122.281 1.988 . . . . 0.0 112.138 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 139.25 38.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.532 2.155 . . . . 0.0 112.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -128.18 5.65 5.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.487 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 146.61 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 60' ' ' ALA . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.803 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' C ' HD21 ' A' ' 53' ' ' LEU . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.763 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.803 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.806 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HD2' HD23 ' A' ' 79' ' ' LEU . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 83' ' ' SER . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.609 HG22 HD22 ' A' ' 86' ' ' LEU . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' N ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.622 ' OE2' HG22 ' A' ' 117' ' ' VAL . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.803 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.636 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.3 mm-40 -73.35 146.28 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.7 147.03 36.73 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.728 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.997 2.465 . . . . 0.0 112.306 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.6 mtt -73.73 172.83 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.56 129.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.877 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.851 ' O ' HD22 ' A' ' 34' ' ' LEU . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 33' ' ' PRO . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.776 HG22 ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.99 -155.58 9.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -69.82 170.78 8.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 34.2 Cg_exo -57.68 -158.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.711 2.274 . . . . 0.0 112.291 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.73 28.97 3.56 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -81.39 146.3 57.4 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.999 0.428 . . . . 0.0 110.786 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 57.6 Cg_exo -50.52 -46.18 30.85 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.515 2.143 . . . . 0.0 112.059 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 2.9 Cg_exo -75.91 80.69 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.774 2.316 . . . . 0.0 112.016 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.0 92.51 4.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.21 133.34 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 HD13 ' A' ' 64' ' ' LEU . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.03 HD11 ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' HZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HZ3' ' HG1' ' A' ' 55' ' ' THR . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.781 HD13 HD23 ' A' ' 49' ' ' LEU . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.586 ' HH2' HD11 ' A' ' 84' ' ' LEU . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' HD23 ' A' ' 86' ' ' LEU . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 83' ' ' SER . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.76 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.586 HD11 ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 117' ' ' VAL . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' CB ' HG13 ' A' ' 89' ' ' VAL . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 49' ' ' LEU . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.877 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.64 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.0 mt-30 -73.01 146.67 45.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.29 145.57 31.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.24 0.618 0 C-N-CA 122.941 2.427 . . . . 0.0 112.387 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.868 0.365 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.01 175.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.31 -172.33 0.03 OUTLIER 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.91 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 34' ' ' LEU . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.1 -101.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 160.48 70.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.725 0.298 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.94 178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.578 2.185 . . . . 0.0 112.293 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -61.93 -18.53 60.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -57.51 157.04 14.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.9 Cg_endo -59.98 130.87 36.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.664 2.243 . . . . 0.0 112.247 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 44.3 Cg_exo -54.94 143.41 72.61 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.258 . . . . 0.0 112.562 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.67 -24.62 10.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.93 146.78 9.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.717 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 64' ' ' LEU . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 55' ' ' THR . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 59' ' ' GLU . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' N ' HD11 ' A' ' 53' ' ' LEU . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 49' ' ' LEU . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.568 ' HH2' HD21 ' A' ' 84' ' ' LEU . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 86' ' ' LEU . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 83' ' ' SER . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 83' ' ' SER . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.694 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 ' HH2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.775 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.518 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.75 HG23 ' OE1' ' A' ' 94' ' ' GLU . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 117' ' ' VAL . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG13 ' HG2' ' A' ' 114' ' ' ARG . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.656 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HG13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.91 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.85 145.88 50.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -111.95 104.2 55.85 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.244 0.82 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.97 159.96 41.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.07 162.71 5.45 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.87 ' HB2' HG21 ' A' ' 89' ' ' VAL . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG22 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.28 -69.83 0.1 OUTLIER Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -62.85 167.45 5.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 51.4 Cg_exo -52.77 -178.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.574 2.183 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -21.32 63.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.41 163.19 60.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.311 . . . . 0.0 110.79 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.72 146.1 28.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.334 2.023 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.29 147.41 36.35 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 122.735 2.29 . . . . 0.0 112.491 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.97 -23.99 11.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.198 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.17 151.25 2.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.82 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 64' ' ' LEU . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.509 HD22 ' HE1' ' A' ' 97' ' ' PHE . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 49' ' ' LEU . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.669 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.669 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.759 ' CD1' HG22 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.476 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 92' ' ' GLN . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HG3' HD12 ' A' ' 91' ' ' ILE . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.598 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' CG ' HG13 ' A' ' 117' ' ' VAL . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.509 ' HE1' HD22 ' A' ' 53' ' ' LEU . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' H ' HG22 ' A' ' 109' ' ' THR . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 101' ' ' ALA . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -73.28 133.99 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.47 137.9 23.41 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.254 1.297 0 C-N-CA 122.256 1.97 . . . . 0.0 111.821 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.6 mtm -140.06 158.11 44.58 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' ASN . . . -177.1 176.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.899 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.829 ' O ' HG12 ' A' ' 89' ' ' VAL . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 33' ' ' PRO . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.47 168.29 11.32 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.23 141.82 90.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 0.0 111.035 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.22 176.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.485 2.123 . . . . 0.0 112.126 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.66 -18.93 17.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.235 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -57.54 -45.49 99.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.275 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -65.57 141.86 68.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.128 . . . . 0.0 112.093 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 52.8 Cg_exo -53.93 88.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.514 2.143 . . . . 0.0 112.41 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -151.18 -175.98 5.38 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.959 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -132.78 175.82 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 64' ' ' LEU . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 61' ' ' TRP . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.62 ' N ' HD21 ' A' ' 53' ' ' LEU . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 49' ' ' LEU . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.736 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 86' ' ' LEU . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.731 ' CD1' HG22 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 32' ' ' GLU . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.77 HG21 ' HD2' ' A' ' 121' ' ' PRO . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.625 ' OE2' HG22 ' A' ' 117' ' ' VAL . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.899 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -111.15 145.91 37.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.36 104.24 53.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HD2' HG21 ' A' ' 91' ' ' ILE . 52.7 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.471 2.114 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.588 0.232 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.8 mmt 60.73 -176.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . 64.72 -173.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' C ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.917 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.87 -44.41 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -60.55 170.21 1.47 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 42.2 Cg_exo -56.72 -162.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.729 2.286 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -58.36 -22.07 52.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -94.72 152.76 40.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.6 141.98 47.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.531 2.154 . . . . 0.0 112.199 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.64 156.55 49.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.58 2.186 . . . . 0.0 112.269 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -101.66 -20.65 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -128.07 136.18 50.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.759 ' CE3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.697 ' CH2' HD21 ' A' ' 84' ' ' LEU . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 78' ' ' VAL . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 79' ' ' LEU . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.899 ' HB2' HG22 ' A' ' 89' ' ' VAL . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 34' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.496 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.812 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 96' ' ' ILE . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 109' ' ' THR . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.882 ' HB ' HG23 ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -105.45 139.8 39.52 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.24 149.17 44.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.588 2.192 . . . . 0.0 112.251 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.942 0.401 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.2 mmm -81.28 -179.22 7.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.158 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.59 158.17 2.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.691 HD11 ' HD2' ' A' ' 113' ' ' TYR . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.925 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' C ' HD12 ' A' ' 34' ' ' LEU . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.64 -78.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.59 119.85 77.42 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.556 0.217 . . . . 0.0 111.309 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.69 170.6 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.529 2.153 . . . . 0.0 111.86 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -59.32 -21.77 60.25 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.67 160.22 36.88 Favored Pre-proline 0 C--O 1.221 -0.424 0 CA-C-O 121.473 0.654 . . . . 0.0 110.659 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 70.3 Cg_exo -51.35 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.802 2.335 . . . . 0.0 111.798 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 45' ' ' PRO . 38.1 Cg_endo -66.48 136.95 44.93 Favored 'Trans proline' 0 C--O 1.216 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 112.169 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -60.14 -27.93 67.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.7 143.47 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.592 HD21 ' N ' ' A' ' 61' ' ' TRP . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.592 ' N ' HD21 ' A' ' 53' ' ' LEU . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HH2' HD21 ' A' ' 84' ' ' LEU . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' SER . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.802 ' CD1' HG22 ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 HD23 ' A' ' 84' ' ' LEU . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 30' ' ' ILE . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 91' ' ' ILE . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.606 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.642 ' CD ' HG22 ' A' ' 117' ' ' VAL . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' ' 96' ' ' ILE . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.691 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.925 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -73.16 145.9 46.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.9 145.38 32.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 122.316 2.01 . . . . 0.0 112.355 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.85 -172.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -172.45 162.37 5.3 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.076 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 113' ' ' TYR . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.821 ' O ' HD22 ' A' ' 34' ' ' LEU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 84' ' ' LEU . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.0 -62.0 0.11 Allowed Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 146.92 88.21 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-O 120.842 0.353 . . . . 0.0 111.123 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.77 -171.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -19.44 62.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 13.2 mttp -53.34 161.28 1.46 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 44' ' ' LYS . 82.6 Cg_exo -47.53 159.77 0.46 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.587 2.191 . . . . 0.0 112.485 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.97 176.92 3.99 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.978 2.452 . . . . 0.0 112.4 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.86 -167.82 0.8 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -54.17 150.14 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.837 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 61' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.715 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.522 ' N ' HD11 ' A' ' 53' ' ' LEU . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HE3' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 64' ' ' LEU . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' HE3' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.686 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB3' HD13 ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.756 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 79' ' ' LEU . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.805 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 34' ' ' LEU . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.772 HG21 ' HD3' ' A' ' 121' ' ' PRO . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' CB ' HG13 ' A' ' 89' ' ' VAL . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.715 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' HD11 ' A' ' 26' ' ' ILE . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.865 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.55 145.57 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -116.26 157.66 44.81 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.121 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.772 ' HD3' HG21 ' A' ' 91' ' ' ILE . 58.5 Cg_endo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.68 2.253 . . . . 0.0 111.846 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 mmt -138.44 159.41 42.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.19 143.72 55.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.848 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.815 ' O ' HD22 ' A' ' 34' ' ' LEU . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.74 -28.1 0.25 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.83 121.32 44.34 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.437 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.71 -164.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 122.221 1.947 . . . . 0.0 111.838 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -19.98 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.88 139.68 46.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.62 112.98 1.22 Allowed 'Trans proline' 0 N--CA 1.475 0.418 0 C-N-CA 122.312 2.008 . . . . 0.0 112.17 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.17 -166.9 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.512 2.141 . . . . 0.0 112.125 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.06 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.397 0.618 . . . . 0.0 111.343 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.66 141.14 42.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.353 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.888 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CD2' ' A' ' 86' ' ' LEU . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 83' ' ' SER . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' OE1' ' A' ' 94' ' ' GLU . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' CB ' HG13 ' A' ' 89' ' ' VAL . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.745 ' CD ' HG22 ' A' ' 117' ' ' VAL . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 102' ' ' MET . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 93' ' ' ASP . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.848 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 30' ' ' ILE . 22.6 mt-30 -84.72 128.84 34.81 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.41 161.33 32.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.783 2.322 . . . . 0.0 111.992 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -79.15 171.26 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -176.03 163.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.922 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.755 ' C ' HD22 ' A' ' 34' ' ' LEU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 33' ' ' PRO . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 84' ' ' LEU . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.01 158.53 9.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -59.78 165.59 4.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.498 0.189 . . . . 0.0 111.065 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 54.4 Cg_exo -51.95 166.74 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 80' ' ' PRO . 1.3 tttm -103.88 15.74 27.96 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 5.9 mtmt -85.77 -47.72 0.58 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 120.791 0.329 . . . . 0.0 111.297 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 84.8 Cg_endo -83.18 140.08 9.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.379 2.053 . . . . 0.0 112.381 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.66 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.264 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.74 147.08 42.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -88.51 145.87 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 64' ' ' LEU . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' C ' ' A' ' 60' ' ' ALA . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 95' ' ' GLY . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' C ' HD21 ' A' ' 53' ' ' LEU . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.54 ' N ' HD11 ' A' ' 53' ' ' LEU . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 49' ' ' LEU . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.59 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 83' ' ' SER . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 85' ' ' PHE . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.587 ' HB3' HD13 ' A' ' 79' ' ' LEU . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.728 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 79' ' ' LEU . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.72 HG22 HD22 ' A' ' 86' ' ' LEU . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' CB ' HG13 ' A' ' 89' ' ' VAL . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.637 ' CD ' HG22 ' A' ' 117' ' ' VAL . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 55' ' ' THR . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 8.5 t30 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.922 ' HB ' HG23 ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.8 mm-40 -73.29 136.68 44.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.08 149.27 42.29 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.473 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.592 2.195 . . . . 0.0 112.28 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.97 152.3 33.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.602 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.26 40.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.409 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.29 15.31 8.4 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB1' ' CD ' ' A' ' 47' ' ' GLN . . . -64.5 128.13 93.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.523 0.201 . . . . 0.0 110.987 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.01 -174.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.267 1.978 . . . . 0.0 112.079 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.82 -20.7 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.227 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -63.72 141.22 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 31.6 Cg_exo -56.94 -45.96 32.55 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.459 2.106 . . . . 0.0 112.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 51.1 Cg_exo -54.07 -35.94 83.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.16 1.907 . . . . 0.0 112.543 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' CD ' ' HB1' ' A' ' 41' ' ' ALA . 3.3 mt-30 62.56 111.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -107.97 133.38 52.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 ' CE1' ' A' ' 97' ' ' PHE . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 53' ' ' LEU . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.557 ' CH2' HD11 ' A' ' 84' ' ' LEU . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 83' ' ' SER . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.758 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CH2' ' A' ' 72' ' ' TRP . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD22 ' OD2' ' A' ' 93' ' ' ASP . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 34' ' ' LEU . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.645 HG21 ' CD ' ' A' ' 121' ' ' PRO . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.797 ' OD2' HD22 ' A' ' 86' ' ' LEU . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 117' ' ' VAL . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.918 ' CE1' HD22 ' A' ' 53' ' ' LEU . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.845 ' HB ' HG23 ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.534 ' O ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.3 139.24 38.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.23 155.96 49.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.976 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' HG21 ' A' ' 91' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.546 2.164 . . . . 0.0 112.325 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.777 0.323 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 81.1 mtp -69.46 160.23 31.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.07 140.26 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.886 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 89' ' ' VAL . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.73 -35.79 0.68 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.23 46.01 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.461 0.172 . . . . 0.0 111.089 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 33.4 Cg_exo -58.33 -158.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.571 2.181 . . . . 0.0 111.748 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.11 -32.38 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.293 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 11.7 mttt -80.66 -64.35 0.3 Allowed Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 44' ' ' LYS . 23.2 Cg_endo -61.02 173.17 2.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.39 2.06 . . . . 0.0 112.101 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 27.2 Cg_endo -62.2 -166.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.747 2.298 . . . . 0.0 112.199 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.95 83.21 2.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.19 138.42 47.66 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.561 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 60' ' ' ALA . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 59' ' ' GLU . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.534 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.86 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 83' ' ' SER . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 83' ' ' SER . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.724 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.86 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 34' ' ' LEU . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.756 HG21 ' CD ' ' A' ' 121' ' ' PRO . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' HD21 ' A' ' 86' ' ' LEU . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.893 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 55' ' ' THR . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 109' ' ' THR . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' HD11 ' A' ' 26' ' ' ILE . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.893 HG22 ' OE2' ' A' ' 94' ' ' GLU . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -84.85 139.02 32.2 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.72 134.63 22.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.168 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.756 ' CD ' HG21 ' A' ' 91' ' ' ILE . 58.2 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.318 2.012 . . . . 0.0 112.553 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.832 0.349 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.36 177.3 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . -59.89 158.47 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.165 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' HD2' ' A' ' 113' ' ' TYR . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.834 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.43 -35.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.19 105.13 0.49 Allowed Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.03 -162.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.224 1.949 . . . . 0.0 112.213 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -68.33 -22.1 64.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -102.2 138.75 19.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.56 110.7 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.749 2.299 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.2 -167.96 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 30.61 0.3 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -165.68 147.76 7.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.796 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 83' ' ' SER . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.834 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.821 HG23 ' OE1' ' A' ' 94' ' ' GLU . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.821 ' OE1' HG23 ' A' ' 91' ' ' ILE . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.581 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.517 ' HD2' HD11 ' A' ' 26' ' ' ILE . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.901 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -72.61 127.45 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -109.95 104.12 54.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.254 1.319 0 C-N-CA 122.468 2.112 . . . . 0.0 112.747 179.788 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.767 0.318 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.65 168.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.71 -177.56 0.11 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.8 ' O ' HD22 ' A' ' 34' ' ' LEU . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.802 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 36' ' ' LEU . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.4 -66.98 0.24 Allowed Glycine 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -64.95 172.38 2.34 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.649 0.262 . . . . 0.0 110.857 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 51.5 Cg_exo -54.26 -166.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.61 2.207 . . . . 0.0 112.426 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -23.28 23.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.319 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -102.3 138.48 19.72 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.1 144.78 56.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.182 1.922 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 73.1 Cg_endo -75.84 147.81 31.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.505 2.136 . . . . 0.0 112.485 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -76.71 -22.11 54.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.106 0.479 . . . . 0.0 111.262 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 141.6 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.704 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.514 ' CZ3' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 60' ' ' ALA . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.798 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.481 ' HH2' HD21 ' A' ' 84' ' ' LEU . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 86' ' ' LEU . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 83' ' ' SER . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.588 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.75 HD22 ' OD2' ' A' ' 93' ' ' ASP . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HB2' ' A' ' 34' ' ' LEU . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' CG2' HG22 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.75 ' OD2' HD22 ' A' ' 86' ' ' LEU . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 117' ' ' VAL . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.702 ' HA ' HG22 ' A' ' 109' ' ' THR . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.702 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.842 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' ILE . 27.9 mt-30 -90.06 145.86 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.849 HG22 ' CG2' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -114.75 104.0 54.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.004 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 91' ' ' ILE . 50.8 Cg_exo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.488 2.125 . . . . 0.0 112.288 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.827 0.346 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' HD12 ' A' ' 34' ' ' LEU . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.788 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LEU . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.689 ' HB2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.699 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.521 ' HA ' HD21 ' A' ' 53' ' ' LEU . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.86 HD21 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.86 ' CZ3' HD21 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 83' ' ' SER . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.799 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.69 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.788 ' CD1' HG22 ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.708 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.621 HG13 ' CB ' ' A' ' 93' ' ' ASP . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.621 ' CB ' HG13 ' A' ' 89' ' ' VAL . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.688 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 HD22 ' A' ' 112' ' ' ASN . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.543 HD22 HG22 ' A' ' 96' ' ' ILE . 1.5 m120 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' HD12 ' A' ' 34' ' ' LEU . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 33' ' ' PRO . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 60' ' ' ALA . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.803 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' C ' HD21 ' A' ' 53' ' ' LEU . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.763 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.803 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.806 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HD2' HD23 ' A' ' 79' ' ' LEU . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 83' ' ' SER . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.609 HG22 HD22 ' A' ' 86' ' ' LEU . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.486 ' N ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.622 ' OE2' HG22 ' A' ' 117' ' ' VAL . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.803 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.636 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.3 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.877 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.851 ' O ' HD22 ' A' ' 34' ' ' LEU . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 33' ' ' PRO . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.776 HG22 ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.589 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 HD13 ' A' ' 64' ' ' LEU . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.03 HD11 ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' HZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HZ3' ' HG1' ' A' ' 55' ' ' THR . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.781 HD13 HD23 ' A' ' 49' ' ' LEU . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.586 ' HH2' HD11 ' A' ' 84' ' ' LEU . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' HD23 ' A' ' 86' ' ' LEU . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 83' ' ' SER . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.76 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.586 HD11 ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 117' ' ' VAL . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' CB ' HG13 ' A' ' 89' ' ' VAL . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 49' ' ' LEU . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.877 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.64 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.0 mt-30 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.439 0 CA-C-O 120.577 0.227 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.91 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 34' ' ' LEU . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.695 0.284 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 64' ' ' LEU . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 55' ' ' THR . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 59' ' ' GLU . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' N ' HD11 ' A' ' 53' ' ' LEU . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 49' ' ' LEU . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.568 ' HH2' HD21 ' A' ' 84' ' ' LEU . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 86' ' ' LEU . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 83' ' ' SER . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 83' ' ' SER . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.694 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 ' HH2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.775 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.518 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.75 HG23 ' OE1' ' A' ' 94' ' ' GLU . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 117' ' ' VAL . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG13 ' HG2' ' A' ' 114' ' ' ARG . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.656 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HG13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.91 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.87 ' HB2' HG21 ' A' ' 89' ' ' VAL . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG22 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 CA-C-O 120.693 0.282 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 64' ' ' LEU . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.509 HD22 ' HE1' ' A' ' 97' ' ' PHE . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 49' ' ' LEU . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.669 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.669 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.759 ' CD1' HG22 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.476 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 92' ' ' GLN . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HG3' HD12 ' A' ' 91' ' ' ILE . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.598 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' CG ' HG13 ' A' ' 117' ' ' VAL . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.509 ' HE1' HD22 ' A' ' 53' ' ' LEU . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' H ' HG22 ' A' ' 109' ' ' THR . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 101' ' ' ALA . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.582 HE21 HD11 ' A' ' 30' ' ' ILE . 30.7 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' ASN . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.899 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.829 ' O ' HG12 ' A' ' 89' ' ' VAL . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 33' ' ' PRO . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 64' ' ' LEU . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 61' ' ' TRP . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.62 ' N ' HD21 ' A' ' 53' ' ' LEU . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 49' ' ' LEU . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.736 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 86' ' ' LEU . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.731 ' CD1' HG22 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 32' ' ' GLU . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.625 ' OE2' HG22 ' A' ' 117' ' ' VAL . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.899 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' C ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.917 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.759 ' CE3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.697 ' CH2' HD21 ' A' ' 84' ' ' LEU . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 79' ' ' LEU . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.899 ' HB2' HG22 ' A' ' 89' ' ' VAL . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 34' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.496 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.812 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 96' ' ' ILE . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 109' ' ' THR . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.882 ' HB ' HG23 ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.265 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.691 HD11 ' HD2' ' A' ' 113' ' ' TYR . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.925 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' C ' HD12 ' A' ' 34' ' ' LEU . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.592 HD21 ' N ' ' A' ' 61' ' ' TRP . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.592 ' N ' HD21 ' A' ' 53' ' ' LEU . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HH2' HD21 ' A' ' 84' ' ' LEU . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' SER . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.802 ' CD1' HG22 ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 HD23 ' A' ' 84' ' ' LEU . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 30' ' ' ILE . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 91' ' ' ILE . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.606 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.642 ' CD ' HG22 ' A' ' 117' ' ' VAL . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' ' 96' ' ' ILE . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.691 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.925 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 CA-C-O 120.71 0.29 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 113' ' ' TYR . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.821 ' O ' HD22 ' A' ' 34' ' ' LEU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 84' ' ' LEU . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.782 0.325 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 61' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.715 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.522 ' N ' HD11 ' A' ' 53' ' ' LEU . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HE3' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 64' ' ' LEU . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' HE3' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.686 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB3' HD13 ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.756 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 79' ' ' LEU . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.805 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 34' ' ' LEU . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' CB ' HG13 ' A' ' 89' ' ' VAL . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.715 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' HD11 ' A' ' 26' ' ' ILE . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.865 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.527 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.848 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.815 ' O ' HD22 ' A' ' 34' ' ' LEU . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.49 0.186 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.888 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CD2' ' A' ' 86' ' ' LEU . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 83' ' ' SER . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' OE1' ' A' ' 94' ' ' GLU . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' CB ' HG13 ' A' ' 89' ' ' VAL . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.745 ' CD ' HG22 ' A' ' 117' ' ' VAL . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 102' ' ' MET . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 93' ' ' ASP . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.848 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 30' ' ' ILE . 6.3 mt-30 . . . . . 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.922 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.755 ' C ' HD22 ' A' ' 34' ' ' LEU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 33' ' ' PRO . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 84' ' ' LEU . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 64' ' ' LEU . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' C ' ' A' ' 60' ' ' ALA . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 95' ' ' GLY . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' C ' HD21 ' A' ' 53' ' ' LEU . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.54 ' N ' HD11 ' A' ' 53' ' ' LEU . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 49' ' ' LEU . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.59 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 83' ' ' SER . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 85' ' ' PHE . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.587 ' HB3' HD13 ' A' ' 79' ' ' LEU . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.728 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 79' ' ' LEU . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.72 HG22 HD22 ' A' ' 86' ' ' LEU . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.563 ' CB ' HG13 ' A' ' 89' ' ' VAL . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.637 ' CD ' HG22 ' A' ' 117' ' ' VAL . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 55' ' ' THR . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 112' ' ' ASN . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 2.8 t-20 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.541 HD22 HG22 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.922 ' HB ' HG23 ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.8 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.536 0.208 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 ' CE1' ' A' ' 97' ' ' PHE . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 53' ' ' LEU . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.557 ' CH2' HD11 ' A' ' 84' ' ' LEU . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 83' ' ' SER . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.758 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CH2' ' A' ' 72' ' ' TRP . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD22 ' OD2' ' A' ' 93' ' ' ASP . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 34' ' ' LEU . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 92' ' ' GLN . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.797 ' OD2' HD22 ' A' ' 86' ' ' LEU . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 117' ' ' VAL . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.918 ' CE1' HD22 ' A' ' 53' ' ' LEU . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.845 ' HB ' HG23 ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.534 ' O ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.886 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 89' ' ' VAL . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 121.116 0.484 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 60' ' ' ALA . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 59' ' ' GLU . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.534 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.86 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 83' ' ' SER . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 83' ' ' SER . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.724 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.86 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 34' ' ' LEU . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' HD21 ' A' ' 86' ' ' LEU . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.893 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 55' ' ' THR . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 109' ' ' THR . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' HD11 ' A' ' 26' ' ' ILE . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.893 HG22 ' OE2' ' A' ' 94' ' ' GLU . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.856 0.36 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' HD2' ' A' ' 113' ' ' TYR . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.834 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.796 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 83' ' ' SER . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.834 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.821 HG23 ' OE1' ' A' ' 94' ' ' GLU . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.821 ' OE1' HG23 ' A' ' 91' ' ' ILE . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.581 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.739 HG22 ' ND2' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.739 ' ND2' HG22 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.517 ' HD2' HD11 ' A' ' 26' ' ' ILE . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.901 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.8 ' O ' HD22 ' A' ' 34' ' ' LEU . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.802 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 36' ' ' LEU . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.05 0.452 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.514 ' CZ3' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 60' ' ' ALA . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.798 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.481 ' HH2' HD21 ' A' ' 84' ' ' LEU . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 86' ' ' LEU . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 83' ' ' SER . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.588 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.75 HD22 ' OD2' ' A' ' 93' ' ' ASP . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HB2' ' A' ' 34' ' ' LEU . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.75 ' OD2' HD22 ' A' ' 86' ' ' LEU . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 117' ' ' VAL . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.702 ' HA ' HG22 ' A' ' 109' ' ' THR . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.702 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.842 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' ILE . 27.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.61 176.9 12.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.96 142.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.987 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -89.25 137.21 32.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.16 111.12 20.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.944 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mt -128.08 125.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.02 140.23 29.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.94 162.7 36.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 138.28 48.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.149 0.5 . . . . 0.0 110.788 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -60.23 131.53 25.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.125 0.488 . . . . 0.0 111.419 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.55 3.36 82.89 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.244 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.19 134.87 22.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.985 0.392 . . . . 0.0 111.033 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' HD12 ' A' ' 34' ' ' LEU . 19.4 Cg_exo -65.68 141.29 65.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.463 2.109 . . . . 0.0 111.923 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.6 mp -140.36 138.52 34.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.007 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.788 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.2 t -124.87 136.46 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LEU . 2.7 mt -143.77 152.5 41.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 124.73 50.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.69 80.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -65.31 -176.15 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.526 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.55 116.07 20.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.345 0.073 . . . . 0.0 110.967 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.21 -166.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.278 1.985 . . . . 0.0 112.221 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -23.02 57.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.42 165.36 9.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.82 167.69 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.6 2.2 . . . . 0.0 112.256 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.29 105.54 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.611 2.208 . . . . 0.0 112.181 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -176.04 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.26 21.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.758 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -158.68 142.71 15.48 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.21 45.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.689 ' HB2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -101.57 131.8 47.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -144.91 141.64 29.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -146.83 144.35 29.26 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.75 125.11 51.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.699 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -148.7 177.67 9.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.44 -53.45 45.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -108.47 -32.12 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m 62.13 104.86 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -140.92 16.67 2.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.083 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.9 -16.01 7.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.57 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.521 ' HA ' HD21 ' A' ' 53' ' ' LEU . 11.1 t90 -57.24 115.95 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.922 0.392 . . . . 0.0 110.752 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 13.7 tmtt? -132.48 156.87 45.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.448 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.4 113.62 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.86 HD21 ' CZ3' ' A' ' 72' ' ' TRP . 4.2 mm? -92.28 136.02 33.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.136 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.85 149.38 73.5 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.696 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 -11.79 33.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 0.0 112.265 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -146.12 75.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.84 164.45 12.25 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.64 166.07 26.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.01 -150.45 6.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 -47.29 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 112.558 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.86 ' CZ3' HD21 ' A' ' 64' ' ' LEU . 43.4 t90 -59.29 -20.35 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.383 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.35 -33.83 68.17 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -24.1 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.288 0.566 . . . . 0.0 111.293 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -84.39 -32.48 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -162.5 142.88 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -122.26 164.95 16.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 110.742 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 83' ' ' SER . 28.7 t -110.55 128.06 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.697 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.1 mm? -72.14 151.01 92.46 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.87 -25.33 11.83 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.896 2.397 . . . . 0.0 112.366 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -85.2 5.7 29.0 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 122.251 -0.28 . . . . 0.0 111.473 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.4 41.67 11.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.305 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.799 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.6 t -108.05 -171.18 1.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.69 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -150.58 125.69 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.922 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.788 ' CD1' HG22 ' A' ' 35' ' ' VAL . 12.9 t80 -128.87 134.45 48.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.069 0.461 . . . . 0.0 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.708 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -116.95 127.96 26.36 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.714 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.46 -34.8 83.1 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.478 2.119 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -167.53 105.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.203 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.621 HG13 ' CB ' ' A' ' 93' ' ' ASP . 24.4 t -75.55 116.84 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.71 14.12 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.632 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -33.12 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -29.86 70.49 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.133 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.621 ' CB ' HG13 ' A' ' 89' ' ' VAL . 4.9 m-20 -77.28 -17.72 58.14 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.688 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -50.92 178.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.603 0.239 . . . . 0.0 111.195 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 99.76 -152.8 19.46 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.997 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 HD22 ' A' ' 112' ' ' ASN . 3.3 mp -126.16 131.28 71.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.924 0.392 . . . . 0.0 110.629 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -99.29 151.11 21.41 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.448 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -144.24 141.95 30.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 m -106.45 153.89 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.03 150.11 20.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.276 0.56 . . . . 0.0 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.72 160.1 38.59 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 14.5 ttt -132.38 112.8 12.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.028 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.15 -172.71 2.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -30.94 71.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.08 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -93.47 -22.23 19.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.05 43.9 1.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.398 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -87.24 126.61 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -125.7 148.76 48.93 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 t -98.51 130.22 45.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -101.79 123.49 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.15 124.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.543 HD22 HG22 ' A' ' 96' ' ' ILE . 1.5 m120 -124.18 125.97 45.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.5 m-85 -114.27 124.27 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 120.49 27.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.607 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.84 133.97 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.402 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.26 145.18 38.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.494 0.664 . . . . 0.0 110.607 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.9 m -95.28 161.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.071 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -52.99 -77.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.09 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.9 125.69 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.048 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.32 163.04 23.34 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.061 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.242 0.69 0 C-N-CA 122.719 2.28 . . . . 0.0 112.553 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.82 0.343 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mtm -134.62 152.24 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.84 175.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.02 159.84 40.45 Favored 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -113.35 118.33 34.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 mt -119.68 137.32 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 p -90.39 140.27 29.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.975 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.15 162.7 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.99 132.55 56.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -56.19 128.46 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.478 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.85 2.49 77.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.144 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 tp10 -97.26 135.85 21.68 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.908 0.354 . . . . 0.0 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' HD12 ' A' ' 34' ' ' LEU . 15.1 Cg_exo -68.29 144.57 62.83 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.477 2.118 . . . . 0.0 112.062 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 33' ' ' PRO . 6.9 mp -145.85 139.3 26.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.4 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 84' ' ' LEU . 17.5 t -126.34 141.19 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.985 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.22 144.55 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.125 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.07 127.38 47.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.763 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 87.06 2.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -69.73 -174.11 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.1 -21.87 1.76 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.26 105.31 0.51 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.563 0.22 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.96 -160.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.899 2.4 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -73.11 -19.46 61.14 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.391 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -100.67 143.71 27.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.59 108.27 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 122.281 1.988 . . . . 0.0 112.138 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 139.25 38.98 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.532 2.155 . . . . 0.0 112.151 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -128.18 5.65 5.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.487 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 146.61 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 110.78 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.17 144.88 17.65 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -139.67 142.93 36.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -104.42 132.58 50.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 110.807 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 18.7 mttt -144.87 138.8 27.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 60' ' ' ALA . 3.3 pp -148.49 158.36 44.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 119.68 30.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.803 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -135.14 176.85 8.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.05 -54.42 37.55 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.02 -26.41 16.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.0 111.201 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 m 64.58 76.91 0.33 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -133.28 18.3 4.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.225 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' C ' HD21 ' A' ' 53' ' ' LEU . . . -115.59 -21.14 9.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.439 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 17.0 t90 -58.08 116.57 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -131.64 150.24 52.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.069 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.0 p -110.94 142.12 24.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.9 mm? -90.57 130.83 36.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.032 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -125.83 144.5 48.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.87 -11.7 23.8 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.617 2.211 . . . . 0.0 112.568 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -132.96 43.16 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.74 178.1 25.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.25 -141.07 4.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.15 171.63 31.46 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 -34.55 70.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.578 2.185 . . . . 0.0 112.294 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.763 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 80.0 t90 -59.82 -20.57 57.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.51 -29.48 36.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -20.03 40.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.24 -38.54 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.062 0.458 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.803 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -164.71 138.45 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 160.77 16.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 t -96.3 118.93 43.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.806 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -67.16 147.56 98.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.818 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HD2' HD23 ' A' ' 79' ' ' LEU . 10.6 Cg_endo -53.74 -22.17 22.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.884 2.39 . . . . 0.0 112.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 83' ' ' SER . 3.1 p-10 -89.23 13.28 13.72 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.123 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.88 21.71 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 13.2 t -130.55 175.15 9.23 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -122.36 140.98 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.656 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -135.64 122.26 20.86 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -112.38 126.07 29.0 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.799 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.69 -57.33 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.625 2.217 . . . . 0.0 111.805 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -141.25 100.68 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.07 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.609 HG22 HD22 ' A' ' 86' ' ' LEU . 24.6 t -79.59 113.92 19.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -116.0 -165.54 14.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.529 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.3 pp -58.73 -38.88 74.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.119 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' N ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-30 -60.93 -26.08 67.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -83.47 -18.33 38.92 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.373 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.622 ' OE2' HG22 ' A' ' 117' ' ' VAL . 49.0 mt-10 -50.62 177.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.845 0.355 . . . . 0.0 111.254 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.803 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 111.85 -156.95 15.26 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.4 130.2 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 56.7 m-85 -106.37 156.87 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -143.62 155.49 44.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 111.081 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.43 154.47 32.41 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.577 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -157.95 140.34 14.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.846 0.355 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.8 39.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.2 ttp -127.52 113.22 15.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -94.01 -174.96 3.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -62.67 -31.02 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.64 -21.61 18.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.56 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 37.9 1.69 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -83.49 132.27 34.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.771 0.319 . . . . 0.0 111.051 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -123.63 148.76 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.259 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.2 t -97.39 130.47 44.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.9 117.69 34.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 113' ' ' TYR . 55.1 m -166.6 112.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.8 121.38 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 110.732 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 111' ' ' SER . 3.2 m-85 -106.55 133.07 51.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.979 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 110.93 23.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.794 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.2 t -103.42 131.05 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.085 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -131.56 138.64 48.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.278 0.561 . . . . 0.0 110.687 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.9 m -95.35 157.1 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.856 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.22 -48.11 81.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.626 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.636 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.3 mm-40 -73.35 146.28 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.827 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.7 147.03 36.73 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.728 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.997 2.465 . . . . 0.0 112.306 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.6 mtt -73.73 172.83 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.56 129.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.72 159.23 28.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -109.55 121.38 45.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.033 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.35 133.8 68.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 123.373 0.421 . . . . 0.0 111.072 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -86.18 140.31 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.152 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.91 162.58 32.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.02 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.877 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -61.26 130.86 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 111.275 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 77.0 2.5 78.07 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.515 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -97.76 130.87 27.98 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 117.186 0.493 . . . . 0.0 111.066 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.851 ' O ' HD22 ' A' ' 34' ' ' LEU . 21.7 Cg_exo -64.39 141.33 74.1 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.404 2.069 . . . . 0.0 112.111 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 33' ' ' PRO . 2.8 mm? -139.86 140.93 36.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.776 HG22 ' CD1' ' A' ' 85' ' ' PHE . 27.8 t -126.24 141.67 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.277 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mt -142.53 140.53 31.82 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.783 0.325 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 126.78 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.1 t -119.28 113.58 21.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.686 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 170.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.103 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.99 -155.58 9.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -69.82 170.78 8.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 34.2 Cg_exo -57.68 -158.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.711 2.274 . . . . 0.0 112.291 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.73 28.97 3.56 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -81.39 146.3 57.4 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.999 0.428 . . . . 0.0 110.786 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 57.6 Cg_exo -50.52 -46.18 30.85 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.515 2.143 . . . . 0.0 112.059 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 2.9 Cg_exo -75.91 80.69 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.774 2.316 . . . . 0.0 112.016 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.0 92.51 4.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.808 0.337 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.21 133.34 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 HD13 ' A' ' 64' ' ' LEU . 2.1 tt -155.69 143.19 19.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -132.66 135.97 46.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.85 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.5 129.53 45.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.01 0.433 . . . . 0.0 110.812 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -139.77 126.61 20.74 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.03 HD11 ' HB1' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -149.19 151.57 34.53 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.6 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -107.82 115.89 30.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.916 0.865 . . . . 0.0 110.752 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' HZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -103.04 168.89 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.028 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.49 -43.75 52.44 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.405 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -107.11 -77.57 0.6 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.753 0.311 . . . . 0.0 110.948 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -176.32 -173.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 60.99 96.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.03 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -178.82 -68.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.498 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HZ3' ' HG1' ' A' ' 55' ' ' THR . 39.4 p90 -58.29 118.88 5.99 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.716 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -125.23 144.17 50.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.59 137.78 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.011 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.781 HD13 HD23 ' A' ' 49' ' ' LEU . 4.8 mp -90.94 126.78 36.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.15 164.07 16.14 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.13 84.56 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.468 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 66.07 79.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.664 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.78 -130.04 1.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.32 -164.41 27.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.96 176.95 43.69 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.337 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.33 -47.06 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.55 2.167 . . . . 0.0 112.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.586 ' HH2' HD11 ' A' ' 84' ' ' LEU . 74.5 t90 -62.06 -22.94 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.16 -45.68 68.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 111.234 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -62.75 -21.07 65.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 111.484 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' HD23 ' A' ' 86' ' ' LEU . 26.1 t -88.67 -33.03 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.257 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -154.95 132.64 11.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.52 140.64 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.161 0.505 . . . . 0.0 110.588 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 83' ' ' SER . 22.3 t -87.56 130.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 148.01 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.45 -25.67 14.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.597 2.198 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.9 0.64 38.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.437 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.16 45.29 5.96 Favored Glycine 0 C--O 1.225 -0.418 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.36 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.76 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.4 t -119.31 -169.53 1.77 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.586 HD11 ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -146.77 135.71 22.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 110.54 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.9 t80 -135.68 138.84 43.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.87 123.54 27.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.59 -36.04 69.72 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.184 1.923 . . . . 0.0 112.436 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.459 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -165.89 108.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -83.5 121.56 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.694 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.444 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -119.75 -161.9 11.73 Favored Glycine 0 C--O 1.238 0.38 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.752 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 117' ' ' VAL . 1.9 pp -64.35 -34.28 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -66.31 -24.0 66.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.478 . . . . 0.0 110.78 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' CB ' HG13 ' A' ' 89' ' ' VAL . 79.0 m-20 -87.22 -13.22 44.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.409 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.5 mt-10 -50.35 177.39 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.893 0.378 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.48 -173.25 18.51 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.095 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.83 146.48 12.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.64 0.257 . . . . 0.0 110.938 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.76 ' CE2' HD13 ' A' ' 53' ' ' LEU . 39.0 m-85 -119.31 153.98 34.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.946 0.403 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 142.9 29.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.83 0.348 . . . . 0.0 110.984 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -102.88 153.93 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -159.04 132.46 7.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 49' ' ' LEU . . . -135.09 159.93 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.36 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.1 113.48 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.836 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -99.86 -178.97 4.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.855 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -59.27 -31.52 69.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.753 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -102.4 21.36 15.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.705 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.4 47.63 85.75 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.901 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -90.43 127.66 36.28 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.846 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.21 148.94 42.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.805 0.336 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 t -100.42 119.55 38.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -95.62 111.51 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -158.06 124.32 4.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.832 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -124.13 122.67 38.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.2 m-85 -122.1 137.83 54.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.051 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 121.33 42.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.337 0.589 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.91 124.89 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -131.66 142.84 49.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.361 0.6 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.877 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.47 159.55 2.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -50.61 -68.55 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.481 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.64 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.0 mt-30 -73.01 146.67 45.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.29 145.57 31.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.24 0.618 0 C-N-CA 122.941 2.427 . . . . 0.0 112.387 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.868 0.365 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.01 175.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.31 -172.33 0.03 OUTLIER 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.144 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 28.2 mm100 -139.28 159.56 41.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -130.88 96.83 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.4 mt -104.93 137.15 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 p -101.33 114.91 29.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.0 111.134 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.05 162.47 16.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CD ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -103.03 139.56 38.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.987 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.91 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -61.54 131.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.479 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.73 2.84 77.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.019 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.5 tp10 -97.39 132.89 24.52 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 116.858 0.329 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 34' ' ' LEU . 16.7 Cg_exo -66.61 138.91 51.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.26 1.973 . . . . 0.0 112.158 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.0 mm? -139.21 140.3 37.74 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.072 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 24.7 t -125.9 135.9 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.99 136.83 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.46 . . . . 0.0 111.052 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 118.46 36.97 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.977 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.37 87.91 2.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.818 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 179.55 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.1 -101.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.347 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.19 160.48 70.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.725 0.298 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.94 178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.578 2.185 . . . . 0.0 112.293 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -61.93 -18.53 60.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -57.51 157.04 14.5 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.9 Cg_endo -59.98 130.87 36.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.664 2.243 . . . . 0.0 112.247 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 44.3 Cg_exo -54.94 143.41 72.61 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.258 . . . . 0.0 112.562 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.67 -24.62 10.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.93 146.78 9.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.717 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 64' ' ' LEU . 7.0 tt -158.77 145.32 17.12 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.0 110.856 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.18 135.47 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.466 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.522 ' CH2' ' CH2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.68 140.89 33.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.886 0.374 . . . . 0.0 111.302 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 9.6 mttm -145.06 134.29 22.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD2' ' CZ3' ' A' ' 51' ' ' TRP . 1.6 pp -148.43 153.27 38.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.004 0.43 . . . . 0.0 111.248 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.18 116.47 31.97 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.5 179.09 7.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 55' ' ' THR . . . -58.13 93.59 0.04 OUTLIER Glycine 0 C--O 1.239 0.448 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.104 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER 69.81 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.635 -0.332 . . . . 0.0 110.565 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.97 140.75 0.04 OUTLIER 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.736 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 pt-20 -179.53 38.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 59' ' ' GLU . . . 171.37 -29.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 111.602 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' N ' HD11 ' A' ' 53' ' ' LEU . 16.2 t90 -57.68 115.9 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -131.94 166.26 22.07 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.88 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.76 128.44 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 49' ' ' LEU . 3.7 mm? -90.69 124.68 35.28 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.059 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 p -130.58 156.13 80.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.58 63.93 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.856 2.371 . . . . 0.0 111.924 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.5 -60.01 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.91 -80.66 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.422 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.8 21.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.27 -149.12 5.11 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.349 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.5 -44.05 3.58 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.487 2.124 . . . . 0.0 112.199 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.568 ' HH2' HD21 ' A' ' 84' ' ' LEU . 8.2 t90 -61.69 -19.84 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.25 -39.21 63.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 t -66.95 -18.62 65.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.645 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 86' ' ' LEU . 21.2 t -92.61 -54.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 111.243 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -138.74 174.48 10.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.188 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 152.29 33.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 83' ' ' SER . 21.5 t -95.54 127.76 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 83' ' ' SER . 69.4 mt -75.1 151.63 86.1 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.52 -24.67 9.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.966 2.444 . . . . 0.0 112.59 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.1 10.54 14.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.545 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.88 41.64 40.72 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.212 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.694 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.8 t -111.54 -171.11 1.77 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 111.146 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 ' HH2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -146.73 126.72 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 15.1 t80 -128.56 141.62 51.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.721 0.296 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -128.75 127.97 23.49 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.778 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.41 -50.91 10.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.568 2.179 . . . . 0.0 111.624 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -143.01 98.4 3.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.901 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.775 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.6 t -76.07 116.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.518 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -137.17 -142.06 4.34 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.738 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.75 HG23 ' OE1' ' A' ' 94' ' ' GLU . 1.9 mp -60.87 -50.86 78.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 122.911 -0.17 . . . . 0.0 111.133 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -55.17 -24.0 24.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.78 0.324 . . . . 0.0 110.578 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.3 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 117' ' ' VAL . 55.3 mt-10 -53.63 178.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 97.93 -170.25 24.92 Favored Glycine 0 CA--C 1.505 -0.55 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.283 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG13 ' HG2' ' A' ' 114' ' ' ARG . 1.6 mp -111.78 134.2 54.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.72 0.295 . . . . 0.0 110.97 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.463 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 99.6 m-85 -108.2 161.15 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 111.183 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -150.55 145.4 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.1 151.73 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -161.15 127.14 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.693 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.91 160.09 39.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.2 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 10.8 ttt -135.34 113.01 10.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -98.47 174.6 6.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -59.09 -31.28 68.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.221 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -84.51 -22.59 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.91 33.78 3.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.281 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -84.38 138.12 33.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.759 0.314 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -128.84 148.81 50.92 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -102.13 116.88 33.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.998 0.428 . . . . 0.0 110.816 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -104.54 113.34 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 125.38 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.299 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -117.77 123.25 45.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.656 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.9 m-85 -126.3 129.47 48.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HG13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -93.93 123.78 37.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.31 117.29 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.52 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.69 150.95 47.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.483 0.659 . . . . 0.0 110.386 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.91 ' HB ' HG23 ' A' ' 30' ' ' ILE . 17.7 m -95.11 161.28 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.22 -67.62 0.3 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.689 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.85 145.88 50.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.043 0.449 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -111.95 104.2 55.85 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.244 0.82 0 C-N-CA 122.493 2.129 . . . . 0.0 112.253 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.97 159.96 41.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.07 162.71 5.45 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.255 0.55 . . . . 0.0 110.804 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -129.97 159.55 36.34 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.027 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -117.47 121.62 41.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.6 mt -124.67 136.86 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.402 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.5 p -86.16 140.24 30.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.495 0.664 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.42 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.83 142.16 46.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.98 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -70.35 133.22 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.115 0.483 . . . . 0.0 111.065 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.87 2.35 81.5 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.033 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -97.32 116.08 65.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.747 0.273 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . 50.1 Cg_exo -55.56 131.26 45.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.207 1.938 . . . . 0.0 112.015 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.87 ' HB2' HG21 ' A' ' 89' ' ' VAL . 1.2 mm? -130.15 145.75 51.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG22 ' CD1' ' A' ' 85' ' ' PHE . 29.0 t -126.62 141.13 46.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.11 135.87 31.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 136.86 32.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.79 71.15 1.36 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.317 0.58 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -178.45 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.922 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.28 -69.83 0.1 OUTLIER Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.229 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -62.85 167.45 5.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 51.4 Cg_exo -52.77 -178.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.574 2.183 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -21.32 63.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.41 163.19 60.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.311 . . . . 0.0 110.79 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.72 146.1 28.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.334 2.023 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.29 147.41 36.35 Favored 'Trans proline' 0 C--O 1.219 -0.465 0 C-N-CA 122.735 2.29 . . . . 0.0 112.491 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.97 -23.99 11.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.198 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.17 151.25 2.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.82 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 64' ' ' LEU . 2.7 tt -158.04 144.76 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.241 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -138.74 136.6 35.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.728 0.411 . . . . 0.0 111.27 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.48 134.54 42.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.623 0.249 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 12.2 mttt -144.18 139.25 28.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.509 HD22 ' HE1' ' A' ' 97' ' ' PHE . 4.5 pp -149.04 158.71 44.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -128.26 121.68 29.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.025 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -147.24 177.18 9.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.8 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.61 -35.96 90.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -43.16 4.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.599 -0.354 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 67.69 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.74 -17.21 11.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.439 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.57 -16.9 46.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 20.0 t90 -57.37 115.98 3.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.36 . . . . 0.0 110.968 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -131.98 136.99 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.378 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.99 134.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 49' ' ' LEU . 2.6 mp -91.02 138.99 31.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.39 165.62 32.8 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 -13.73 41.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.779 2.319 . . . . 0.0 112.286 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -176.17 97.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.71 -73.54 0.04 OUTLIER Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.517 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.83 14.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.593 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.83 177.56 31.05 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.66 -37.12 9.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.742 2.294 . . . . 0.0 112.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.669 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 62.6 t90 -58.81 -24.64 62.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.059 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.3 -50.12 72.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -18.47 65.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.75 -32.58 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -161.6 154.7 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 164.77 27.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.19 120.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 142.08 91.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.74 -28.21 29.31 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.055 1.837 . . . . 0.0 112.683 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.61 -10.8 59.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.53 43.15 2.37 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.477 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.0 t -128.19 -172.67 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.561 0.22 . . . . 0.0 110.976 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.669 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -145.02 113.62 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.892 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.759 ' CD1' HG22 ' A' ' 35' ' ' VAL . 9.4 t80 -108.27 132.46 53.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 5.3 mp -113.58 117.94 44.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.904 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.03 -40.05 86.76 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.367 2.045 . . . . 0.0 112.463 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.65 106.58 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.309 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.9 t -97.28 120.73 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.476 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -151.03 -141.2 3.31 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.751 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 92' ' ' GLN . 2.3 pp -55.51 -28.51 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HG3' HD12 ' A' ' 91' ' ' ILE . 1.3 mt-30 -75.7 -6.45 50.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.598 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -111.5 -15.87 13.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.605 0.241 . . . . 0.0 111.316 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' CG ' HG13 ' A' ' 117' ' ' VAL . 41.8 mt-10 -51.96 178.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.243 -0.286 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.497 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 89.01 -161.41 30.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.262 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mt -109.22 131.53 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.74 0.305 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.509 ' HE1' HD22 ' A' ' 53' ' ' LEU . 12.0 m-85 -106.79 154.95 20.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.121 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -147.87 139.41 23.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 111.063 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.94 154.3 21.28 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.884 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -160.32 117.35 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' H ' HG22 ' A' ' 109' ' ' THR . . . -117.75 116.71 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 7.0 tpp -81.89 122.94 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.218 0.532 . . . . 0.0 110.899 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.69 -170.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.836 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -66.01 -28.29 68.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.366 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -102.58 22.11 14.15 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.461 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.14 41.47 99.7 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.363 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -88.36 151.6 22.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 110.397 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.7 148.81 50.86 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.114 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 101' ' ' ALA . 5.2 t -98.74 117.13 32.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.597 0.236 . . . . 0.0 111.1 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.69 120.12 21.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.672 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 4.4 m -166.26 119.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.982 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.91 115.99 15.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.0 OUTLIER -122.56 138.11 54.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.921 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 107.68 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.34 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.77 133.16 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.051 0.453 . . . . 0.0 111.779 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -135.37 144.3 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.315 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 30' ' ' ILE . 11.8 m -95.23 158.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.95 0.405 . . . . 0.0 111.288 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -54.31 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.511 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.582 HE21 HD11 ' A' ' 30' ' ' ILE . 30.7 mt-30 -73.28 133.99 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.47 137.9 23.41 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.254 1.297 0 C-N-CA 122.256 1.97 . . . . 0.0 111.821 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 53.6 mtm -140.06 158.11 44.58 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' ASN . . . -177.1 176.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 159.57 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -113.59 113.3 24.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.29 137.51 50.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.2 139.99 29.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.1 162.29 35.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.34 132.48 56.59 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 123.396 0.435 . . . . 0.0 110.831 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.899 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.32 129.81 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.55 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 73.47 6.19 69.86 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.37 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.829 ' O ' HG12 ' A' ' 89' ' ' VAL . 32.9 tp10 -97.08 126.45 42.26 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.828 0.314 . . . . 0.0 111.01 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.26 145.73 93.34 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.512 2.142 . . . . 0.0 111.876 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 33' ' ' PRO . 2.8 mp -148.39 146.1 28.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.055 0.455 . . . . 0.0 111.308 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -124.48 141.37 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -144.32 141.06 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.995 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 122.2 46.72 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -97.71 118.56 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.401 0.62 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 171.25 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.982 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.47 168.29 11.32 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.446 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.23 141.82 90.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 0.0 111.035 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.22 176.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.485 2.123 . . . . 0.0 112.126 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.66 -18.93 17.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.235 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -57.54 -45.49 99.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.275 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -65.57 141.86 68.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.128 . . . . 0.0 112.093 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 52.8 Cg_exo -53.93 88.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.514 2.143 . . . . 0.0 112.41 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -151.18 -175.98 5.38 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.959 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -132.78 175.82 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 64' ' ' LEU . 3.9 tt -158.51 137.63 11.48 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -138.35 139.79 39.19 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -99.65 136.95 38.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.605 0.241 . . . . 0.0 110.915 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -145.07 147.0 32.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.804 0.335 . . . . 0.0 110.899 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 61' ' ' TRP . 3.0 pp -144.69 149.77 36.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -108.16 115.99 31.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.16 175.19 12.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.16 -37.28 86.79 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.14 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.69 86.7 2.28 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 p -52.58 91.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.625 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -115.28 -16.26 11.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 72' ' ' TRP . . . -102.25 -17.0 16.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.62 ' N ' HD21 ' A' ' 53' ' ' LEU . 10.5 t90 -57.41 115.94 3.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 110.941 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.61 152.89 49.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.42 139.59 31.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 HD22 ' A' ' 49' ' ' LEU . 4.0 mp -90.72 125.71 35.77 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.91 157.66 47.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.913 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.38 57.57 5.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.584 2.189 . . . . 0.0 112.875 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -178.79 -55.13 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.31 126.47 2.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.6 140.47 3.02 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 117.75 1.28 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -52.36 -28.63 35.78 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.537 2.158 . . . . 0.0 111.844 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.736 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 42.0 t90 -62.9 -20.02 64.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.201 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.78 -29.96 42.49 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 110.85 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -77.03 -17.65 58.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.183 0.516 . . . . 0.0 111.322 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 86' ' ' LEU . 21.6 t -94.06 -32.68 4.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.218 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -161.34 148.25 14.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.181 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 161.28 18.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.43 112.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 1.2 mp -66.68 145.83 98.99 Favored Pre-proline 0 C--O 1.226 -0.179 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.757 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.61 -19.46 37.44 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.798 2.332 . . . . 0.0 112.524 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -83.74 4.63 28.02 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.25 44.6 7.43 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.18 -0.534 . . . . 0.0 112.564 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 7.4 t -122.44 -179.9 4.36 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -147.6 117.98 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.984 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.731 ' CD1' HG22 ' A' ' 35' ' ' VAL . 21.9 t80 -118.97 124.98 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.154 0.284 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -105.13 126.38 31.15 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.37 -38.96 93.44 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 122.569 2.18 . . . . 0.0 111.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -163.24 101.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.12 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 32' ' ' GLU . 12.1 p -77.6 114.74 18.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.707 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -112.67 -160.97 15.05 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.085 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.77 HG21 ' HD2' ' A' ' 121' ' ' PRO . 19.3 pt -63.22 -35.99 74.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -66.88 -26.47 66.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -77.52 -24.39 50.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.625 ' OE2' HG22 ' A' ' 117' ' ' VAL . 47.5 mt-10 -49.0 173.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 118.39 -156.86 15.47 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.573 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mt -124.89 123.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.119 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 51' ' ' TRP . 94.3 m-85 -99.28 161.15 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.6 149.88 30.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.176 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.48 154.28 20.57 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.513 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.67 143.65 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.224 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.57 159.96 39.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.82 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.63 112.99 19.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 11.8 t30 -94.42 -177.95 4.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -56.63 -30.73 63.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.43 . . . . 0.0 111.106 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -100.75 -22.72 14.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.795 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.66 30.68 2.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.357 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 74.8 tttt -75.7 137.11 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 111.165 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -118.59 149.26 41.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 110.519 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' THR . 10.9 t -94.83 120.54 35.22 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.002 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.1 136.44 37.89 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.92 125.67 0.68 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 4.4 t-20 -127.61 115.61 19.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.213 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.13 129.43 55.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.912 0.387 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.36 117.31 34.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.863 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.63 127.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.823 0.344 . . . . 0.0 111.337 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -132.31 147.9 52.41 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.789 0.804 . . . . 0.0 110.661 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.899 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.6 m -95.45 160.24 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.23 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.273 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -111.15 145.91 37.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.36 104.24 53.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HD2' HG21 ' A' ' 91' ' ' ILE . 52.7 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.471 2.114 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.588 0.232 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.8 mmt 60.73 -176.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . 64.72 -173.2 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.198 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -136.56 159.59 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -113.41 98.05 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.036 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.46 137.32 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.975 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -88.62 140.03 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.082 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 162.45 35.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.999 0.428 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 147.78 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.909 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -76.61 132.84 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.32 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.19 3.39 88.38 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.195 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 17.7 tp10 -96.97 129.06 33.38 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.929 0.365 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' C ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.48 132.83 37.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.515 2.144 . . . . 0.0 112.067 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.917 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.7 mp -137.38 143.74 42.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.558 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' CD1' ' A' ' 85' ' ' PHE . 30.9 t -126.27 141.25 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mt -144.4 148.86 35.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 127.5 56.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.33 75.1 1.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -93.12 -177.05 4.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.87 -44.41 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.503 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -60.55 170.21 1.47 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.656 0.265 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 42.2 Cg_exo -56.72 -162.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.729 2.286 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -58.36 -22.07 52.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -94.72 152.76 40.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.6 141.98 47.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.531 2.154 . . . . 0.0 112.199 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.64 156.55 49.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.58 2.186 . . . . 0.0 112.269 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -101.66 -20.65 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -128.07 136.18 50.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.64 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 tt -158.37 149.08 20.41 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -136.46 147.52 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.759 ' CE3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.07 135.67 53.95 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.185 0.517 . . . . 0.0 111.028 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 mttm -142.24 127.07 18.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.72 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 51' ' ' TRP . 1.3 mt -130.13 159.38 36.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.025 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -123.95 116.12 22.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.799 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.812 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -145.22 161.22 40.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.63 73.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.987 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 58' ' ' THR . 23.2 tpt180 -100.86 -15.0 17.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.591 0.234 . . . . 0.0 111.292 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 57' ' ' ARG . 14.7 t 45.78 43.5 9.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.864 0.364 . . . . 0.0 111.783 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.55 -20.64 13.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' C ' HD12 ' A' ' 53' ' ' LEU . . . -80.81 -22.81 39.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 13.2 t90 -58.42 121.47 10.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -128.32 145.9 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.365 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.19 142.39 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.941 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.9 mm? -90.88 131.03 36.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.26 153.12 81.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.62 -12.32 35.18 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.598 2.199 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -130.1 29.76 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.459 0.475 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.97 177.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.13 108.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.08 143.34 3.64 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.894 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.04 -34.82 3.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.697 ' CH2' HD21 ' A' ' 84' ' ' LEU . 90.2 t90 -61.39 -23.23 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.84 -45.51 86.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.802 0.334 . . . . 0.0 110.671 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -24.25 63.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.39 -36.2 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -149.88 148.93 29.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -130.06 146.39 51.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.123 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.3 p -87.62 113.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.36 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -64.28 147.44 97.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.96 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 79' ' ' LEU . 54.0 Cg_exo -52.87 -22.33 17.75 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.864 2.376 . . . . 0.0 112.375 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.03 11.89 12.65 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.497 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.86 39.13 39.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -119.21 177.11 5.01 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD21 ' CH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -139.43 133.18 30.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.738 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.2 t80 -136.01 138.26 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.899 ' HB2' HG22 ' A' ' 89' ' ' VAL . 0.8 OUTLIER -130.76 125.09 21.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.764 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.38 -62.24 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.432 2.088 . . . . 0.0 112.226 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.45 84.87 2.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.904 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 34' ' ' LEU . 15.6 t -73.47 113.57 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.496 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -150.24 -122.87 1.13 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.656 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.83 -27.64 31.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.91 0.386 . . . . 0.0 111.467 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -75.13 -6.73 51.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.436 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -19.25 12.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.542 0.21 . . . . 0.0 111.345 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.786 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.5 mt-10 -56.16 171.68 0.25 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 111.006 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.812 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.41 -163.12 33.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.409 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 96' ' ' ILE . 4.0 mp -103.82 126.83 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 3.6 m-85 -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -124.73 144.04 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.47 154.35 24.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 117.23 3.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.55 27.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.19 117.05 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.38 -178.93 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.57 -30.7 71.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -87.36 -13.14 44.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.385 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.69 61.65 1.22 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -119.25 159.12 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.97 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.526 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 109' ' ' THR . 13.6 t -97.05 117.17 30.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.982 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.92 111.49 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.898 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.84 108.77 1.36 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.003 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 2.1 t-20 -121.99 118.9 29.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -124.57 121.06 33.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.235 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -90.16 118.7 29.88 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.431 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 21.5 t -116.0 134.57 58.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.626 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -131.71 143.11 50.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.761 0.791 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.882 ' HB ' HG23 ' A' ' 30' ' ' ILE . 12.2 m -95.14 156.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.415 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -58.57 -74.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -105.45 139.8 39.52 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.827 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.24 149.17 44.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.588 2.192 . . . . 0.0 112.251 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.942 0.401 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.2 mmm -81.28 -179.22 7.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.158 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.59 158.17 2.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 113' ' ' TYR . 15.7 mm100 -119.58 159.34 24.55 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -115.77 100.96 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.691 HD11 ' HD2' ' A' ' 113' ' ' TYR . 3.7 mt -110.86 137.43 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -94.3 126.16 39.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.58 162.6 24.58 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.128 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -112.49 140.48 47.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.925 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -68.95 136.86 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.416 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.06 2.05 70.66 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.616 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 4.5 tp10 -97.36 140.74 22.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 117.174 0.487 . . . . 0.0 111.073 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' C ' HD12 ' A' ' 34' ' ' LEU . 11.8 Cg_exo -69.83 137.28 34.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.457 2.105 . . . . 0.0 111.755 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -136.85 137.73 40.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.3 t -123.8 141.34 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.234 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -145.38 149.85 35.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.286 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 122.38 47.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 97.72 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.95 153.19 17.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.123 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.64 -78.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.086 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.59 119.85 77.42 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.556 0.217 . . . . 0.0 111.309 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.69 170.6 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.529 2.153 . . . . 0.0 111.86 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -59.32 -21.77 60.25 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -91.67 160.22 36.88 Favored Pre-proline 0 C--O 1.221 -0.424 0 CA-C-O 121.473 0.654 . . . . 0.0 110.659 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 70.3 Cg_exo -51.35 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.802 2.335 . . . . 0.0 111.798 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 45' ' ' PRO . 38.1 Cg_endo -66.48 136.95 44.93 Favored 'Trans proline' 0 C--O 1.216 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 112.169 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -60.14 -27.93 67.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.7 143.47 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.921 0.391 . . . . 0.0 110.924 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 tt -158.5 144.89 17.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.907 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.74 134.57 32.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.484 ' CH2' ' CZ2' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -99.72 136.06 40.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.715 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -145.06 139.74 27.61 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.592 HD21 ' N ' ' A' ' 61' ' ' TRP . 1.4 pp -144.05 138.73 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -101.17 117.8 35.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.562 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.12 176.37 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.737 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.55 -38.28 78.78 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -135.19 88.82 2.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.337 . . . . 0.0 110.524 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -51.46 93.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.02 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.73 -1.72 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.351 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.54 -16.23 11.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.592 ' N ' HD21 ' A' ' 53' ' ' LEU . 11.0 t90 -57.53 123.39 15.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 0.0 110.953 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -129.1 147.71 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.82 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.6 t -101.85 131.54 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.4 mm? -100.27 129.84 46.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -130.16 156.62 79.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.63 -11.79 32.89 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.557 2.172 . . . . 0.0 112.602 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -160.67 79.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.26 -152.14 7.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.04 165.14 38.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.3 21.93 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.349 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.99 -41.23 76.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.654 2.236 . . . . 0.0 112.048 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HH2' HD21 ' A' ' 84' ' ' LEU . 47.0 t90 -59.47 -28.66 67.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.817 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.64 -47.1 73.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -19.35 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.33 -40.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.249 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 72' ' ' TRP . . . -139.21 154.11 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.975 0.417 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.18 132.79 30.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' SER . 14.9 p -86.42 116.78 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.2 OUTLIER -61.69 148.56 86.79 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.53 -22.77 36.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.028 2.485 . . . . 0.0 112.531 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -80.13 -1.43 40.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.96 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.6 39.04 6.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.307 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.9 t -114.82 -173.64 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.9 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -151.98 122.03 7.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.793 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.802 ' CD1' HG22 ' A' ' 35' ' ' VAL . 16.9 t80 -129.6 137.58 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 HD23 ' A' ' 84' ' ' LEU . 3.3 mp -128.69 126.1 23.25 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.56 -55.86 2.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.395 2.063 . . . . 0.0 112.418 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.33 102.23 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.296 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.1 t -95.02 112.76 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 30' ' ' ILE . . . -130.07 -151.11 7.11 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.988 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 92' ' ' GLN . 2.0 pp -53.59 -39.38 37.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 91' ' ' ILE . 51.5 mt-30 -59.14 -21.81 59.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.045 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.606 ' CB ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -94.29 -8.31 39.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.584 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.642 ' CD ' HG22 ' A' ' 117' ' ' VAL . 42.4 mt-10 -59.33 -178.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.348 0.594 . . . . 0.0 110.638 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 87.33 -163.1 33.97 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.51 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 113' ' ' TYR . 3.1 mp -114.35 146.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.754 0.312 . . . . 0.0 111.051 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.64 153.09 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -144.04 141.28 30.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.6 m -103.35 153.8 20.06 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.14 130.6 6.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.81 159.7 41.27 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 28.5 tpp -131.12 113.5 13.98 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.345 0.593 . . . . 0.0 110.687 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -95.34 175.5 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.48 -30.75 69.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.3 p30 -89.05 -22.48 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.564 0.54 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.13 33.2 3.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.72 132.35 35.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.924 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.53 148.78 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.2 t -101.96 138.93 38.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.669 0.271 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.78 122.48 28.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.8 108.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' ' 96' ' ' ILE . 6.6 t30 -113.36 116.67 30.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.605 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.691 ' HD2' HD11 ' A' ' 26' ' ' ILE . 5.0 m-85 -122.76 137.85 54.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 129.92 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.911 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.36 121.64 57.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -124.47 139.29 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.826 0.822 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.925 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.5 m -96.68 152.67 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -50.75 -57.91 7.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.995 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -73.16 145.9 46.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.344 0.402 . . . . 0.0 111.018 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.9 145.38 32.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 122.316 2.01 . . . . 0.0 112.355 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.769 0.319 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.85 -172.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -172.45 162.37 5.3 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.076 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.75 159.32 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -110.18 110.26 21.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.057 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 113' ' ' TYR . 2.2 mt -112.51 134.28 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.63 137.68 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.55 162.68 32.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -118.45 134.15 55.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -58.21 124.41 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.231 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.72 80.47 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.827 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -96.92 131.72 27.29 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.763 0.282 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.821 ' O ' HD22 ' A' ' 34' ' ' LEU . 19.5 Cg_exo -65.9 144.47 76.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.622 2.215 . . . . 0.0 112.192 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD22 ' O ' ' A' ' 33' ' ' PRO . 3.2 mm? -139.82 135.92 33.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.292 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 84' ' ' LEU . 21.9 t -125.93 141.49 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.06 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.3 154.29 41.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.321 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.96 122.77 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.811 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.7 t -133.54 72.3 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.58 149.44 24.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.0 -62.0 0.11 Allowed Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 146.92 88.21 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-O 120.842 0.353 . . . . 0.0 111.123 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.77 -171.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -19.44 62.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 13.2 mttp -53.34 161.28 1.46 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.174 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 44' ' ' LYS . 82.6 Cg_exo -47.53 159.77 0.46 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.587 2.191 . . . . 0.0 112.485 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.97 176.92 3.99 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.978 2.452 . . . . 0.0 112.4 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.86 -167.82 0.8 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.824 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -54.17 150.14 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.837 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tt -153.16 143.18 22.23 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.7 143.05 50.85 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.37 136.76 47.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -145.12 136.34 24.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 61' ' ' TRP . 1.6 pp -148.89 159.92 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -123.42 124.73 43.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.299 0.571 . . . . 0.0 110.823 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.715 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -142.2 169.29 17.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.983 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -59.97 5.36 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -80.01 -29.18 39.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.26 95.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.58 26.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.5 -24.6 2.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.793 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.522 ' N ' HD11 ' A' ' 53' ' ' LEU . 7.9 t90 -58.04 115.86 3.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.761 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HE3' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.9 166.4 21.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 64' ' ' LEU . 9.4 p -117.02 155.43 18.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' HE3' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -95.15 139.01 32.09 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.973 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -130.46 153.79 81.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.29 59.07 4.54 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -178.1 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.32 175.85 42.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.45 -153.11 26.0 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.991 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.8 -90.89 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.679 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.32 -49.95 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.547 2.165 . . . . 0.0 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.686 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 63.7 t90 -81.42 -16.09 53.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.381 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.51 -37.88 63.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.608 0.242 . . . . 0.0 110.91 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 t -72.71 -19.23 61.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.137 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -86.32 -32.22 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.297 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -176.18 174.44 2.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.6 164.24 32.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.42 128.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.276 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 83' ' ' SER . 7.2 mp -78.93 151.49 76.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -48.18 -28.05 10.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 112.915 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.92 8.08 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.752 0.657 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.87 22.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.036 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB3' HD13 ' A' ' 79' ' ' LEU . 1.9 t -108.84 -170.66 1.7 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.801 0.334 . . . . 0.0 111.229 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.756 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 tp -142.85 134.48 26.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.26 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HB2' HD11 ' A' ' 79' ' ' LEU . 4.1 t80 -132.15 120.13 21.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.805 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mp -106.61 115.21 60.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.03 -23.81 70.45 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.134 1.889 . . . . 0.0 111.954 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -168.17 112.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG21 ' HB2' ' A' ' 34' ' ' LEU . 19.8 t -96.1 115.31 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.32 -164.01 14.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.434 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.772 HG21 ' HD3' ' A' ' 121' ' ' PRO . 1.8 pp -60.51 -37.26 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.008 0.433 . . . . 0.0 111.062 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -61.79 -26.41 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' CB ' HG13 ' A' ' 89' ' ' VAL . 5.6 m-20 -80.14 -19.1 48.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.069 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.718 ' OE2' HG22 ' A' ' 117' ' ' VAL . 39.3 mt-10 -49.83 175.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.715 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 104.13 -165.91 15.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.155 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.2 mt -114.38 147.31 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 111.334 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.4 m-85 -123.91 147.65 47.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -133.36 145.49 50.41 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.864 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 154.2 19.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.964 0.411 . . . . 0.0 111.09 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -161.18 129.97 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.69 160.38 35.6 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.108 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.29 112.9 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -93.56 -173.77 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -66.01 -33.57 76.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.88 -22.35 22.07 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.432 0.457 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.22 34.47 2.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -83.84 136.94 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 111.104 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -129.1 148.97 51.09 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.2 t -105.42 117.14 33.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -98.17 115.83 29.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.22 117.6 3.52 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -108.89 120.94 44.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.39 0.614 . . . . 0.0 110.768 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' CD2' HD11 ' A' ' 26' ' ' ILE . 4.4 m-85 -113.74 136.84 52.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.927 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 128.62 42.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.277 0.561 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.63 116.91 47.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.38 148.52 50.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.586 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.865 ' HB ' HG23 ' A' ' 30' ' ' ILE . 21.1 m -95.8 157.63 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.533 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.86 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.11 0.481 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -111.55 145.57 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -116.26 157.66 44.81 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.121 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.772 ' HD3' HG21 ' A' ' 91' ' ' ILE . 58.5 Cg_endo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.68 2.253 . . . . 0.0 111.846 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.3 mmt -138.44 159.41 42.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.19 143.72 55.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -129.68 153.3 48.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.66 98.11 7.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.51 137.27 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.121 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.1 p -89.63 140.21 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.53 162.32 35.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -117.75 133.72 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.948 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.848 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -58.08 129.06 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.385 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.62 80.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.024 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 tp10 -97.46 127.45 37.94 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.876 0.338 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.815 ' O ' HD22 ' A' ' 34' ' ' LEU . 14.8 Cg_exo -67.65 136.06 37.94 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.08 1.853 . . . . 0.0 112.464 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mm? -139.81 145.47 38.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 85' ' ' PHE . 26.7 t -126.24 134.51 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.175 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 36' ' ' LEU . 1.8 mt -138.15 138.95 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 125.4 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -126.24 79.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -173.87 4.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.74 -28.1 0.25 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.749 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.83 121.32 44.34 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.437 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.71 -164.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 122.221 1.947 . . . . 0.0 111.838 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -19.98 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.88 139.68 46.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.62 112.98 1.22 Allowed 'Trans proline' 0 N--CA 1.475 0.418 0 C-N-CA 122.312 2.008 . . . . 0.0 112.17 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.17 -166.9 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.512 2.141 . . . . 0.0 112.125 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.06 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.397 0.618 . . . . 0.0 111.343 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.66 141.14 42.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.353 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tt -158.66 149.11 19.92 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 120.74 0.305 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.91 142.68 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.19 0.519 . . . . 0.0 110.75 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.33 139.64 37.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 14.9 mttm -141.61 127.2 18.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.677 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 pp -148.05 160.02 43.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.085 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -132.57 126.09 32.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.547 0.689 . . . . 0.0 110.78 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.09 165.01 26.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.83 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.33 -57.71 18.42 Favored Glycine 0 CA--C 1.51 -0.275 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.59 58.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.16 93.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -168.04 29.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.311 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.45 -20.38 4.41 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.782 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 28.7 t90 -57.19 117.59 4.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.176 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -131.74 156.94 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.817 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.64 133.14 61.9 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.102 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.76 122.25 33.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.22 155.39 40.29 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.11 -12.62 32.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.471 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.25 -54.39 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.81 -168.22 21.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.826 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.46 -138.28 3.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.442 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.75 169.85 29.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.35 -26.87 16.85 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.522 2.148 . . . . 0.0 111.946 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.888 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.8 t90 -59.94 -20.58 58.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.47 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -53.29 -40.05 64.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.834 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -60.92 -21.18 63.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.326 0.584 . . . . 0.0 111.182 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CD2' ' A' ' 86' ' ' LEU . 39.7 t -94.62 -69.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.931 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . . . -129.84 171.04 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 149.16 29.47 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.225 0.535 . . . . 0.0 110.798 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 83' ' ' SER . 15.9 t -81.81 138.81 18.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 6.8 mp -83.77 149.75 57.61 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.95 -24.99 11.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.89 2.393 . . . . 0.0 112.303 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -85.89 7.98 22.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.96 37.31 25.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.227 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.3 t -114.69 -174.42 2.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.75 0.31 . . . . 0.0 111.087 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -137.52 138.5 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.685 ' CD1' HG22 ' A' ' 35' ' ' VAL . 10.5 t80 -135.95 126.69 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.603 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 4.5 mt -118.14 121.6 31.2 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.54 -38.74 80.84 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 112.087 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.25 96.49 2.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.345 0.593 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 34' ' ' LEU . 21.4 t -79.74 117.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.54 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.32 -144.98 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.582 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' OE1' ' A' ' 94' ' ' GLU . 3.4 pt -56.01 -29.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.328 . . . . 0.0 111.411 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -67.88 -23.6 65.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' CB ' HG13 ' A' ' 89' ' ' VAL . 9.1 t70 -91.6 -24.58 19.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.661 0.267 . . . . 0.0 111.211 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.745 ' CD ' HG22 ' A' ' 117' ' ' VAL . 39.6 mt-10 -53.91 174.84 0.05 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.03 -148.3 18.95 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.47 123.09 62.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.862 0.363 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.33 154.79 19.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -144.15 148.62 35.29 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.994 0.426 . . . . 0.0 111.168 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.02 154.01 21.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.698 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 123.77 3.7 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.746 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.68 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.021 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 102' ' ' MET . 0.0 OUTLIER -134.19 112.81 11.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.811 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.53 -178.98 4.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.712 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -59.53 -28.5 67.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.093 0.473 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.19 -21.66 18.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.015 0.436 . . . . 0.0 111.568 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.75 46.89 1.23 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.544 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -97.61 136.09 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -129.18 149.11 51.13 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 t -101.85 129.01 47.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.995 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -97.68 120.51 38.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.64 110.91 1.33 Allowed 'General case' 0 C--O 1.23 0.074 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -108.51 124.39 50.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -117.45 128.59 55.15 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.31 116.31 28.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 93' ' ' ASP . 4.2 t -112.9 133.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -134.46 137.93 44.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.848 ' HB ' HG23 ' A' ' 30' ' ' ILE . 19.4 m -94.97 156.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-O 121.04 0.448 . . . . 0.0 110.955 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -61.63 -74.43 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.835 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.406 ' O ' HG21 ' A' ' 30' ' ' ILE . 6.3 mt-30 -84.72 128.84 34.81 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.304 0.377 . . . . 0.0 110.958 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.41 161.33 32.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.783 2.322 . . . . 0.0 111.992 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.886 0.374 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -79.15 171.26 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -176.03 163.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -116.41 159.27 22.23 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -127.36 101.91 6.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.012 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.7 137.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 p -96.02 127.39 41.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.757 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.88 162.48 29.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.109 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -109.37 134.28 52.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.937 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.922 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -55.18 135.79 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.247 0.546 . . . . 0.0 111.337 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 76.89 2.91 79.09 Favored Glycine 0 C--O 1.227 -0.331 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.832 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -97.26 134.21 23.0 Favored Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 122.411 -0.464 . . . . 0.0 111.061 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.755 ' C ' HD22 ' A' ' 34' ' ' LEU . 6.4 Cg_exo -74.07 135.52 21.09 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.675 2.25 . . . . 0.0 111.481 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 33' ' ' PRO . 4.0 mm? -136.77 139.48 41.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 84' ' ' LEU . 33.3 t -126.71 141.6 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.16 152.46 44.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.95 125.4 54.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 126.46 48.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -53.36 144.8 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.143 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.01 158.53 9.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.429 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -59.78 165.59 4.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.498 0.189 . . . . 0.0 111.065 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 54.4 Cg_exo -51.95 166.74 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 80' ' ' PRO . 1.3 tttm -103.88 15.74 27.96 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 5.9 mtmt -85.77 -47.72 0.58 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 120.791 0.329 . . . . 0.0 111.297 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 84.8 Cg_endo -83.18 140.08 9.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.379 2.053 . . . . 0.0 112.381 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.66 95.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.264 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.74 147.08 42.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -88.51 145.87 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.817 0.342 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 64' ' ' LEU . 6.0 tt -158.4 139.95 13.55 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -130.32 137.69 50.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HZ2' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.9 128.08 47.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.23 138.58 36.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.746 0.307 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' C ' ' A' ' 60' ' ' ALA . 1.2 pp -148.83 153.46 38.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -110.57 122.33 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.344 . . . . 0.0 110.846 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 95' ' ' GLY . 2.1 p -148.94 150.11 32.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.98 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -64.03 3.58 Favored Glycine 0 CA--C 1.509 -0.333 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.705 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -25.33 64.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.33 95.1 0.06 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -160.56 72.07 0.46 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.778 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' C ' HD21 ' A' ' 53' ' ' LEU . . . 175.98 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.54 ' N ' HD11 ' A' ' 53' ' ' LEU . 27.2 t90 -57.05 116.02 2.97 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -130.93 148.21 52.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 127.38 64.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.737 HD22 HD22 ' A' ' 49' ' ' LEU . 6.6 mp -91.32 123.75 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.386 0.612 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.96 164.95 15.15 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.857 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.79 -13.07 38.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -168.53 90.91 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.173 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.57 -144.54 9.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.682 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.89 -151.22 8.56 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.588 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 170.13 41.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.13 -37.16 87.18 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.628 2.219 . . . . 0.0 112.382 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.59 ' CZ2' ' HB3' ' A' ' 76' ' ' ALA . 30.3 t90 -70.05 -25.44 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -52.79 -29.68 28.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.199 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.4 t -78.0 -22.62 49.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.97 -32.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -157.21 154.46 29.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -133.86 171.36 14.28 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.007 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 83' ' ' SER . 26.3 t -108.15 134.47 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 85' ' ' PHE . 7.0 mp -79.73 148.08 68.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.879 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 76.6 Cg_exo -49.66 -25.51 11.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.767 2.311 . . . . 0.0 112.521 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -85.44 5.77 29.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.585 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.06 38.53 15.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.587 ' HB3' HD13 ' A' ' 79' ' ' LEU . 3.0 t -111.83 -179.42 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.695 0.283 . . . . 0.0 111.066 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.728 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -133.41 132.18 40.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.191 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 79' ' ' LEU . 2.7 t80 -128.36 130.69 48.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -121.28 122.58 28.07 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.77 -48.59 17.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.397 2.064 . . . . 0.0 112.192 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB1' ' HA2' ' A' ' 31' ' ' GLY . . . -153.14 105.03 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.257 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.72 HG22 HD22 ' A' ' 86' ' ' LEU . 27.8 t -76.97 118.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.59 -167.65 13.99 Favored Glycine 0 C--O 1.238 0.362 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.379 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 pp -56.75 -37.75 54.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 111.413 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -67.01 -25.96 66.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' CB ' HG13 ' A' ' 89' ' ' VAL . 28.8 m-20 -78.53 -22.41 47.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.637 ' CD ' HG22 ' A' ' 117' ' ' VAL . 46.2 mt-10 -48.3 173.28 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.494 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 55' ' ' THR . . . 115.83 -159.65 13.73 Favored Glycine 0 C--N 1.321 -0.272 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.384 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 HD22 ' A' ' 112' ' ' ASN . 3.2 mt -125.85 128.47 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 7.2 m-85 -103.23 155.65 18.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.42 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -149.83 140.63 22.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.9 m -103.0 154.05 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.28 144.01 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.139 0.495 . . . . 0.0 110.601 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.5 160.48 38.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.793 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.95 112.88 18.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.354 0.597 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 2.8 t-20 -100.49 176.35 5.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -59.08 -29.47 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -103.68 19.51 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.323 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.64 52.21 44.91 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.738 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 49.2 tttt -96.99 123.67 40.77 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.848 0.356 . . . . 0.0 111.283 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.85 148.73 38.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.262 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -97.17 120.21 37.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.831 0.348 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 120.39 31.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -171.15 110.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.541 HD22 HG22 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -114.59 127.27 55.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.357 0.598 . . . . 0.0 110.657 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 111' ' ' SER . 1.5 m-85 -121.16 130.31 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.972 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 128.73 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.671 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.05 131.74 72.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -132.68 139.03 47.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.528 0.68 . . . . 0.0 110.291 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.922 ' HB ' HG23 ' A' ' 30' ' ' ILE . 23.2 m -95.18 153.9 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -47.68 -75.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.509 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.8 mm-40 -73.29 136.68 44.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.288 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.08 149.27 42.29 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.473 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.592 2.195 . . . . 0.0 112.28 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.97 152.3 33.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.602 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.26 40.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.409 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.24 159.47 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -113.77 107.53 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.6 mt -110.45 137.36 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.21 133.07 34.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.88 160.44 38.23 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -112.38 137.16 50.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -62.37 134.83 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.6 7.97 66.13 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.972 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.62 134.67 22.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.856 0.328 . . . . 0.0 111.077 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 18.4 Cg_exo -66.05 132.87 31.35 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.453 2.102 . . . . 0.0 111.994 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' HB2' HG21 ' A' ' 89' ' ' VAL . 5.2 mp -134.56 144.95 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 85' ' ' PHE . 22.5 t -123.35 137.16 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.09 134.12 49.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 110.565 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 131.76 53.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.43 114.62 8.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.007 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.41 -173.17 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.29 15.31 8.4 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.97 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB1' ' CD ' ' A' ' 47' ' ' GLN . . . -64.5 128.13 93.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.523 0.201 . . . . 0.0 110.987 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.01 -174.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.267 1.978 . . . . 0.0 112.079 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.82 -20.7 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.227 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -63.72 141.22 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 31.6 Cg_exo -56.94 -45.96 32.55 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.459 2.106 . . . . 0.0 112.341 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 45' ' ' PRO . 51.1 Cg_exo -54.07 -35.94 83.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.16 1.907 . . . . 0.0 112.543 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' CD ' ' HB1' ' A' ' 41' ' ' ALA . 3.3 mt-30 62.56 111.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -107.97 133.38 52.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -158.76 149.06 19.69 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.396 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.31 138.04 44.67 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.631 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.445 ' CH2' ' CD1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -101.59 130.63 47.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -144.79 141.54 29.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.783 0.325 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD22 ' CE1' ' A' ' 97' ' ' PHE . 2.5 pp -149.04 140.63 23.44 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.045 0.45 . . . . 0.0 110.834 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.91 130.07 49.84 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -152.14 179.75 8.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.612 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . . . -61.6 -70.19 1.1 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.642 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -32.02 70.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.811 0.339 . . . . 0.0 110.97 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.78 71.01 0.5 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.184 0.516 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -150.12 88.51 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.712 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB3' HD21 ' A' ' 53' ' ' LEU . . . -178.23 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.006 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 12.1 p-90 -57.5 136.05 56.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.545 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 145.45 51.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.61 123.82 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 5.0 mp -91.08 127.54 36.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -99.96 163.53 18.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.33 -11.58 32.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.608 2.205 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 28.56 6.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.28 164.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.32 129.18 3.17 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.072 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.98 149.41 5.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.296 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.55 -37.53 3.06 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.294 1.996 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.557 ' CH2' HD11 ' A' ' 84' ' ' LEU . 42.4 t90 -64.83 -23.36 67.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -52.45 -36.26 54.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t -62.38 -22.88 66.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.5 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.301 0.572 . . . . 0.0 110.842 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' ' CH2' ' A' ' 72' ' ' TRP . . . -123.54 157.84 32.72 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.827 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.26 158.38 41.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.469 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 83' ' ' SER . 37.7 t -89.19 130.49 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 79' ' ' LEU . 3.0 mm? -72.08 151.88 92.65 Favored Pre-proline 0 C--O 1.228 -0.072 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.55 -24.1 27.67 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.82 2.347 . . . . 0.0 112.262 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.46 8.11 26.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.314 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.87 40.36 12.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.758 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.1 t -112.69 -165.61 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.553 0.216 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CH2' ' A' ' 72' ' ' TRP . 4.0 tt -154.35 118.5 4.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CD1' HG22 ' A' ' 35' ' ' VAL . 27.8 t80 -117.64 133.73 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD22 ' OD2' ' A' ' 93' ' ' ASP . 3.0 mp -114.98 125.99 28.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.31 -62.29 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.334 2.023 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.02 103.59 8.39 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.43 0.633 . . . . 0.0 111.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 34' ' ' LEU . 26.0 t -89.53 113.42 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 117' ' ' VAL . . . -131.83 -150.64 6.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.645 HG21 ' CD ' ' A' ' 121' ' ' PRO . 1.9 pp -55.7 -33.06 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 111.396 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -66.85 -15.42 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.797 ' OD2' HD22 ' A' ' 86' ' ' LEU . 1.5 m-20 -97.47 -21.33 17.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 111.428 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 117' ' ' VAL . 51.5 mt-10 -49.85 174.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.237 -0.29 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 100.88 -170.94 22.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.274 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.97 125.81 59.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.637 0.256 . . . . 0.0 111.317 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.918 ' CE1' HD22 ' A' ' 53' ' ' LEU . 83.6 m-85 -98.7 144.11 28.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.987 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 145.98 47.24 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -103.14 153.94 19.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -152.84 137.83 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.093 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.03 160.02 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.793 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 9.4 ttt -131.75 112.9 12.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -93.95 -171.01 2.45 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -60.81 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -93.34 -22.34 19.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.185 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.86 40.74 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.942 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 103' ' ' ASN . 43.9 tttt -78.96 130.98 36.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.31 148.93 34.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -97.58 129.74 44.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 129.66 42.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -171.28 141.98 1.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.163 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -147.08 115.47 6.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.25 121.52 36.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 127.41 41.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.554 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.17 133.82 67.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.954 0.406 . . . . 0.0 111.81 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.31 142.13 51.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.473 0.654 . . . . 0.0 110.039 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.845 ' HB ' HG23 ' A' ' 30' ' ' ILE . 5.7 m -94.88 154.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -68.06 -80.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.322 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.534 ' O ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.3 139.24 38.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.23 155.96 49.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.976 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' HG21 ' A' ' 91' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.546 2.164 . . . . 0.0 112.325 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.777 0.323 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 81.1 mtp -69.46 160.23 31.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.07 140.26 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.54 150.2 50.28 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.83 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -98.95 102.65 14.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' A' ' 113' ' ' TYR . 4.2 mt -119.47 133.84 64.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -92.03 132.51 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.5 160.18 34.87 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.146 0.498 . . . . 0.0 110.761 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.09 133.97 55.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 0.0 111.01 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.886 HG23 ' HB ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -61.18 128.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.556 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 0.89 81.31 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.062 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -97.37 119.06 63.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.829 0.314 . . . . 0.0 111.045 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.8 141.03 96.02 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.027 1.818 . . . . 0.0 112.376 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 89' ' ' VAL . 3.6 mt -140.07 149.15 42.76 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.014 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.785 HG22 ' CD1' ' A' ' 85' ' ' PHE . 23.1 t -126.25 139.27 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mt -139.03 145.73 39.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.869 -0.151 . . . . 0.0 111.327 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 119.91 40.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 91.06 3.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.016 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -176.28 5.25 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.009 0.433 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.73 -35.79 0.68 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.23 46.01 Favored Pre-proline 0 CA--C 1.528 0.127 0 CA-C-O 120.461 0.172 . . . . 0.0 111.089 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 33.4 Cg_exo -58.33 -158.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.571 2.181 . . . . 0.0 111.748 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.11 -32.38 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.293 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 11.7 mttt -80.66 -64.35 0.3 Allowed Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 44' ' ' LYS . 23.2 Cg_endo -61.02 173.17 2.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.39 2.06 . . . . 0.0 112.101 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 27.2 Cg_endo -62.2 -166.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.747 2.298 . . . . 0.0 112.199 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.95 83.21 2.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.19 138.42 47.66 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.561 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -154.7 145.99 22.93 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.76 144.86 47.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CE2' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.37 131.89 45.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.627 0.251 . . . . 0.0 111.083 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' TRP . 16.2 mttt -145.09 133.63 22.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 60' ' ' ALA . 2.0 pp -142.6 159.67 41.78 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 120.51 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.77 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' CG2' ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -140.77 154.67 46.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.81 -53.76 32.48 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -11.93 59.81 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.285 0.088 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 72.55 -159.5 0.1 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 76.58 160.31 0.22 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.814 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 59' ' ' GLU . . . 77.53 -0.4 2.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.652 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CD1' ' HA ' ' A' ' 52' ' ' LYS . 21.2 t90 -89.73 115.68 27.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.684 0.278 . . . . 0.0 111.189 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 51' ' ' TRP . 3.8 tmtm? -131.92 152.28 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.57 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.99 121.38 32.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 0.0 110.994 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.71 165.22 36.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.813 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.3 -11.64 32.59 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.464 2.109 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.78 87.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.03 -167.11 34.42 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.9 142.93 3.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.536 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -136.64 173.14 22.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.473 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.16 -25.67 30.4 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.68 2.254 . . . . 0.0 111.946 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.534 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 50.4 t90 -56.43 -25.91 51.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -53.8 -45.22 70.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -19.98 50.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.13 -32.51 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.86 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -171.36 135.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 147.64 42.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 110.929 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 83' ' ' SER . 21.9 t -90.13 120.34 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 83' ' ' SER . 4.2 mt -66.89 151.09 97.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.31 -19.33 27.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.359 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -87.63 11.72 14.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.413 0.446 . . . . 0.0 111.361 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.44 44.1 22.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.724 ' O ' HG13 ' A' ' 78' ' ' VAL . 5.7 t -121.12 -174.37 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.768 0.318 . . . . 0.0 110.839 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.4 OUTLIER -147.72 115.5 6.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.376 0.608 . . . . 0.0 110.52 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 35' ' ' VAL . 11.8 t80 -115.37 131.64 56.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.938 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.86 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 4.7 mp -111.63 116.5 50.22 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.658 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.36 69.63 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.416 2.077 . . . . 0.0 112.261 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.8 108.46 1.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.341 0.591 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.991 HG21 HD12 ' A' ' 34' ' ' LEU . 21.9 t -95.57 112.78 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -122.01 -157.24 9.93 Favored Glycine 0 C--O 1.224 -0.472 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.756 HG21 ' CD ' ' A' ' 121' ' ' PRO . 1.5 pp -62.29 -34.49 64.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.32 -22.44 64.89 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' HD21 ' A' ' 86' ' ' LEU . 19.3 m-20 -89.52 -17.75 28.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.501 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.893 ' OE2' HG22 ' A' ' 117' ' ' VAL . 48.4 mt-10 -51.21 177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 55' ' ' THR . . . 102.85 -153.65 18.25 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.173 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.0 135.51 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.744 0.307 . . . . 0.0 110.944 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 160.88 15.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.208 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.56 139.94 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 153.74 19.85 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 109' ' ' THR . 2.5 tt0 -157.54 119.05 3.65 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.61 115.54 30.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.756 0.312 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.67 121.71 26.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.142 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.39 -172.17 3.01 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.975 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -62.99 -30.08 71.32 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.79 -22.77 18.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 106.8 44.82 1.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.367 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -85.1 158.13 20.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.605 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.31 149.0 51.29 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -100.77 138.62 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.954 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.76 20.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.329 0.585 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.9 m -152.21 134.23 14.95 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -145.01 125.59 14.1 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' HD11 ' A' ' 26' ' ' ILE . 6.2 m-85 -130.22 128.74 42.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 133.51 35.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.323 0.582 . . . . 0.0 110.555 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.54 124.39 54.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.28 146.48 50.42 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.658 0.742 . . . . 0.0 110.482 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.893 HG22 ' OE2' ' A' ' 94' ' ' GLU . 10.7 m -95.43 156.7 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.579 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.76 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.195 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -84.85 139.02 32.2 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.272 0.357 . . . . 0.0 111.072 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.72 134.63 22.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.168 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.756 ' CD ' HG21 ' A' ' 91' ' ' ILE . 58.2 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.318 2.012 . . . . 0.0 112.553 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.832 0.349 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.36 177.3 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' ASN . . . -59.89 158.47 10.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.165 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -113.41 159.13 19.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -112.94 111.49 22.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' HD2' ' A' ' 113' ' ' TYR . 10.3 mt -131.3 137.54 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 111.298 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.3 p -99.08 133.82 42.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.363 0.602 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.36 162.74 32.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -108.54 148.67 29.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.901 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -73.97 129.38 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.387 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.46 79.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.731 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -97.26 133.8 23.5 Favored Pre-proline 0 CA--C 1.529 0.152 0 O-C-N 122.514 -0.403 . . . . 0.0 111.043 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 34' ' ' LEU . 24.2 Cg_exo -63.62 148.2 92.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.46 2.106 . . . . 0.0 111.947 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.834 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.4 mp -149.79 142.7 24.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.394 . . . . 0.0 111.109 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 85' ' ' PHE . 28.6 t -126.26 139.57 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.922 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.25 153.39 42.75 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.407 0.622 . . . . 0.0 110.74 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 118.85 36.39 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.736 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 100.55 10.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -178.81 2.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.43 -35.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.552 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.19 105.13 0.49 Allowed Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.03 -162.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.224 1.949 . . . . 0.0 112.213 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -68.33 -22.1 64.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -102.2 138.75 19.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.611 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.56 110.7 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.749 2.299 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.2 -167.96 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 30.61 0.3 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -165.68 147.76 7.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tt -158.61 148.07 19.23 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.504 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -134.62 145.24 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.172 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.22 138.6 42.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -145.23 147.04 31.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -148.86 159.75 43.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -127.97 120.67 28.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.2 OUTLIER -152.56 177.14 10.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.32 -62.04 5.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.152 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.79 62.42 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.039 0.447 . . . . 0.0 110.396 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.64 103.3 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 27.0 0.33 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.776 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -124.29 -10.44 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.831 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -57.06 115.87 2.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -132.02 154.47 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.99 132.91 61.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.368 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.28 135.94 33.45 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.98 154.5 82.04 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.0 -12.32 34.05 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 112.477 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -164.18 83.97 0.43 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.11 -83.59 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.59 165.03 34.56 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.466 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.46 -168.1 12.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.08 -37.82 7.9 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.586 2.191 . . . . 0.0 112.241 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.796 ' CZ2' HD21 ' A' ' 84' ' ' LEU . 63.5 t90 -58.52 -24.93 61.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.87 -47.43 71.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -62.42 -20.99 65.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.95 -49.52 14.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB2' ' HG ' ' A' ' 86' ' ' LEU . . . -141.25 152.26 44.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 138.06 53.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.475 . . . . 0.0 111.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 83' ' ' SER . 21.8 t -94.51 124.97 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.016 0.436 . . . . 0.0 110.816 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.8 mp -73.8 152.33 89.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.29 -23.2 22.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.112 2.542 . . . . 0.0 112.251 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -84.58 5.18 28.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.307 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.31 40.3 11.46 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.365 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 t -107.41 -174.98 2.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.764 0.316 . . . . 0.0 111.313 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' CZ2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -154.4 108.91 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.38 0.61 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.722 ' CD1' HG22 ' A' ' 35' ' ' VAL . 17.2 t80 -110.94 128.66 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.725 ' HG ' ' HB2' ' A' ' 76' ' ' ALA . 2.9 mp -114.05 128.2 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.64 -52.98 5.76 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.351 2.034 . . . . 0.0 112.273 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.45 98.7 4.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.376 0.608 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.834 HG21 ' HB2' ' A' ' 34' ' ' LEU . 25.0 t -81.03 114.22 21.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.781 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.69 -149.82 5.99 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.259 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.821 HG23 ' OE1' ' A' ' 94' ' ' GLU . 2.5 mp -57.83 -41.79 80.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 111.225 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -55.38 -23.32 23.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 97' ' ' PHE . 9.3 t70 -95.96 -16.13 21.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.221 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.821 ' OE1' HG23 ' A' ' 91' ' ' ILE . 39.4 mt-10 -55.34 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.833 0.349 . . . . 0.0 111.049 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.581 ' HA3' HG23 ' A' ' 55' ' ' THR . . . 93.17 -149.56 19.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.435 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.739 HG22 ' ND2' ' A' ' 112' ' ' ASN . 1.8 mp -125.85 125.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.766 0.317 . . . . 0.0 111.568 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 93' ' ' ASP . 51.7 m-85 -98.96 149.47 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.47 147.66 45.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.88 154.29 21.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.791 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.06 144.26 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.151 0.5 . . . . 0.0 110.641 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 159.83 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.233 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 11.9 tpp -127.68 112.93 15.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.843 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.81 178.9 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -62.09 -30.57 71.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.616 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.75 -22.32 19.44 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.355 0.41 . . . . 0.0 111.118 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.11 50.38 0.83 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.39 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.53 140.11 36.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.72 149.05 46.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.1 t -95.53 117.13 29.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.39 108.62 16.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.311 0.577 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.92 134.29 15.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.739 ' ND2' HG22 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -139.52 129.72 25.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.362 0.601 . . . . 0.0 110.457 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.517 ' HD2' HD11 ' A' ' 26' ' ' ILE . 4.9 m-85 -128.38 128.62 44.85 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.079 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.14 129.48 40.71 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.21 132.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.593 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 142.67 50.49 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.901 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -95.23 157.22 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.285 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.7 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -72.61 127.45 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.875 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -109.95 104.12 54.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.254 1.319 0 C-N-CA 122.468 2.112 . . . . 0.0 112.747 179.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.767 0.318 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.4 mtt 60.65 168.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.246 0.546 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.71 -177.56 0.11 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -137.11 150.05 47.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -107.93 106.84 17.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -119.45 134.22 63.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.94 140.16 30.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.25 160.74 38.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.7 130.3 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.497 0.498 . . . . 0.0 110.968 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -56.43 130.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.22 1.55 80.96 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.6 tp10 -97.63 134.55 22.33 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.837 0.319 . . . . 0.0 110.993 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.8 ' O ' HD22 ' A' ' 34' ' ' LEU . 17.3 Cg_exo -66.58 140.55 57.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.481 2.121 . . . . 0.0 112.181 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.802 ' HB2' HG21 ' A' ' 89' ' ' VAL . 3.3 mm? -139.56 132.26 28.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.246 -0.284 . . . . 0.0 111.341 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -125.85 141.12 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 36' ' ' LEU . 5.7 mt -148.91 140.52 23.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.44 . . . . 0.0 110.972 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.79 81.31 1.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.97 -174.35 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.4 -66.98 0.24 Allowed Glycine 0 C--O 1.239 0.423 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.242 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 42' ' ' PRO . . . -64.95 172.38 2.34 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.649 0.262 . . . . 0.0 110.857 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 41' ' ' ALA . 51.5 Cg_exo -54.26 -166.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.61 2.207 . . . . 0.0 112.426 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -23.28 23.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.319 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -102.3 138.48 19.72 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.1 144.78 56.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.182 1.922 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 73.1 Cg_endo -75.84 147.81 31.36 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.505 2.136 . . . . 0.0 112.485 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -76.71 -22.11 54.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.106 0.479 . . . . 0.0 111.262 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 141.6 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.704 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 tt -158.16 146.78 18.99 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.3 138.56 40.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.043 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.514 ' CZ3' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.27 124.03 44.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.076 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -135.12 134.59 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.557 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 60' ' ' ALA . 3.8 pp -148.81 159.41 44.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.957 0.408 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.18 140.63 49.51 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.45 175.97 11.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.699 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.36 -57.7 8.04 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.257 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -82.64 -17.46 44.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.942 0.401 . . . . 0.0 111.532 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p 56.96 91.97 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.09 35.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.798 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . -120.42 -35.62 3.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.153 0.501 . . . . 0.0 111.433 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -58.01 128.77 38.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.004 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.86 135.01 53.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.676 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -94.41 138.0 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.7 mm? -93.27 123.28 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -128.23 141.26 40.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.781 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.9 -12.33 32.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.292 1.995 . . . . 0.0 112.53 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.83 -38.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.318 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.74 -111.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.64 -138.63 6.03 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.256 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.77 149.17 5.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.36 -29.44 13.86 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.774 2.316 . . . . 0.0 112.234 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.481 ' HH2' HD21 ' A' ' 84' ' ' LEU . 11.6 t90 -64.32 -23.19 67.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -52.65 -41.68 64.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.274 0.559 . . . . 0.0 111.175 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -19.6 62.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.437 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -96.99 -73.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 86' ' ' LEU . . . -127.32 171.84 11.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.159 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 153.58 31.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 83' ' ' SER . 11.7 p -79.9 132.1 32.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 83' ' ' SER . 3.1 mp -75.14 150.16 85.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.54 -24.04 11.85 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.693 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.92 13.18 11.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.36 48.6 23.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.631 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.3 t -125.33 -167.98 1.76 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.685 0.278 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -140.77 135.68 31.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.588 ' CD1' HG22 ' A' ' 35' ' ' VAL . 6.7 t80 -135.96 125.02 24.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.75 HD22 ' OD2' ' A' ' 93' ' ' ASP . 1.2 mt -118.17 118.23 34.41 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.71 -55.22 3.72 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.341 2.027 . . . . 0.0 112.191 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.48 102.27 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HB2' ' A' ' 34' ' ' LEU . 23.5 t -83.83 115.09 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 111.421 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.86 -161.09 11.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' CG2' HG22 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -60.55 -33.75 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 0.0 111.179 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -67.55 -17.83 64.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.465 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.75 ' OD2' HD22 ' A' ' 86' ' ' LEU . 17.0 m-20 -92.34 -17.8 24.19 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.384 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 117' ' ' VAL . 45.2 mt-10 -49.52 175.24 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.57 -170.44 17.27 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.121 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 1.3 mp -104.32 146.57 11.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.438 0.161 . . . . 0.0 111.137 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 53' ' ' LEU . 22.0 m-85 -118.99 139.3 51.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.58 0.229 . . . . 0.0 111.29 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -136.05 143.27 44.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.16 154.11 30.61 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.578 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.702 ' HA ' HG22 ' A' ' 109' ' ' THR . 53.9 tt0 -155.88 117.41 3.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.69 115.94 29.94 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.848 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 3.2 tpp -81.88 121.72 26.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.352 0.596 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -92.74 -170.44 2.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.14 -32.81 74.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.058 0.456 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.17 -22.15 20.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.049 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.36 39.97 1.85 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -83.2 154.85 24.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.075 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.95 148.73 50.96 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.647 0.26 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.702 HG22 ' HA ' ' A' ' 100' ' ' GLN . 12.8 t -98.1 138.38 35.48 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -98.64 121.79 41.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 111.069 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.6 m -168.4 129.21 1.29 Allowed 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.884 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -144.43 116.31 8.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 121.307 0.575 . . . . 0.0 110.621 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -120.84 137.05 54.75 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 116.3 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.54 130.78 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -132.96 139.74 47.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.781 0.8 . . . . 0.0 110.637 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.842 ' HB ' HG23 ' A' ' 30' ' ' ILE . 15.7 m -94.77 155.65 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.11 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.116 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' ILE . 27.9 mt-30 -90.06 145.86 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.849 HG22 ' CG2' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -114.75 104.0 54.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.004 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 91' ' ' ILE . 50.8 Cg_exo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.488 2.125 . . . . 0.0 112.288 -179.988 . . . . . . . . 1 1 . 1 stop_ save_